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Abstract 
Tricliosanthin (TCS) is a ribosome-inactivating protein (RIP) whicli is 
an active compotient of Tiati hua fen (THF), the root tuber of the Chinese 
medicinal herb Trichosanthes kirilowii Maximowicz. TCS has been used in 
abortifacient purposes and the clinical trials on HIV-infected patients. 
However, hypetseiisitivity response is elicited in certain cases. My project 
concerns with location of the antigenic determinants in this protein. 
Transposoii mediated deletion mutagenesis and protein fragmentation 
have been used to find the antigenic determinants of TCS. It was found that 
the polyclonal antibody, classical monoclonal antibody and Fab fragment 
employed recognized a discontinuous epitope on TCS. The forty two clones 
of Fab fragments produced by recombinant method were found to produce 
similar binding pattern towards the deletion mutants. The binding pattern is 
also identical to that of the monoclonal antibody used. The antigenic sites of 
this protein were shown to locate between amino acids residues 1-21, 21-73 
and 154-247. Residues 102-153 of TCS was found to recognize only by the 
anti-TCS polyclonal antibody. Residues 74-100 did not show antigenicity 
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Trichosanthin (TCS) is a ribosome-inactivating protein (RIP) which 
is the active component of Tiati hua fen (THF), the root tuber of the 
Chinese medicinal herb; Trichosanihes kirilowii Maxitnowicz of 
Cucurbitaceae family. THF had been used for abortifacient purpose in 
China for centuries. In the 70s, the active ingredient of THF, TCS, was 
found and purified (Wang et al., 1976). This has led to the initiation of the 
investigation for the use of TCS as abortifiacient agents for birth control in 
China (Liu et al, 1985; Jin, 1985). 
TCS has also been used in the treatment of trophoblastic timiours, 
ectopic pregnancy and retention of dead fetuses (Jiti, 1985; Egarter, et al., 
1991; Huang, 1987). These properties are due to the specific cytotoxicity 
to trophoblasts (Anonymous, 1976). In recent years, TCS has also been 
found to irfiibit the replication of type 1 human immuiio-deficieticy virus 
(HIV-1) in vitro with the additional property of destroying HIV-infected 
macrophages (McGrath et al., 1989). This has led to the phases I & II 
clinical trials to test for the treatment of AIDS by the TCS protein (Byers 
et a!-, 1990; Pinching, 1990). However，one problem in using TCS in 
clinical treatment is that TCS can elicit hypersensitivity response (Byers et 
al., 1990; Pinching, 1990; Jin, 1985; Guowu et al., 1985) and limited 
information on the antigenic sites of TCS protein has been found. 
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1.1 Chemical and Biological Properties of TCS 
1.1.1 Chemical properties 
TCS purified from root tubers of T. kmlowii Maxim was free of 
carbohydrate and phosphate groups. It is a highly basic protein which has 
a pi value of 9.4 as determined by glycerol gradient isoelectric focusing 
method (Jin, 1985; Wang, 1985). 
In recent years the cDNA (Shaw et al., 1991) and the genomic 
DNA (Chow et al., 1990) of TCS have been cloned. The cDNA of TCS 
encodes for a prepropeptide of 289 amino acids (Shaw et al., 1991). The 
first 23 residues resemble a secretary signal peptide and the last 19 amino 
acid residues comprise a propeptide which is cleaved in post-translational 
processing (Chow et al., 1991). It has been shown that the propeptide 
keeps the cytotoxic protein in less active form (Zlui et al, 1992). Mature 
TCS consists of 247 amino acids (Fig. 1.1) (Chow et al, 1990; Shaw et 
a!., 1991) which contains no cysteine residues, therefore no disulfide 
linkage can be formed. The molecular weight of TCS as calculated from 
the amino acid sequence is 27140 (Chow et aL, 1990; Shaw et al., 1991). 
An efficient expression system has been developed for the expression of 
TCS in E. coli (Zhu et al., 1992). 
Recently, the three-dimensional structure of TCS has been solved 
by X-ray crystallography to 1.7A resolution (Dong et al., 1994) and Fig 
1.2 shows the 3-D structure of TCS protein. The 3-D structures of ticin A 




1 Met Asp Val Ser Phe Arg Leu Ser Gly Ala Thr Ser Ser Ser Tyr Gly Val Phe lie Ser 20 
1 ATG GAT GTT AGC TTC CGT TTA TCA GGT GCA ACA AGC AGT TCC TAT GGA GTT TTC ATT TCA 60 
21 Asn Leu Arg Lys Ala Leu Pro Asn Glu Arg Lys Leu Tyr Asp lie Pro Leu Leu Arg Ser 40 
61 AAT CTG AGA AAA GCT CTT CCA AAT GAA AGG AAA CTG TAG GAT ATC CCT CTG TTA CGT TCC 120 
41 Ser Leu Pro Gly Ser Gin Arg Tyr Ala Leu lie His Leu Tbr Asn Tyr Ala Asp Glu Thr 60 
121 TCT CTT CCA GGT TCT CAA CGC TAG GCA TTG ATC CAT CTC ACA AAT TAG GCC GAT GAA ACC ISO 
61 lie Ser Val Ala lie Asp Val Thr Asn Val Tyr lie Met Gly Tyr Arg Ala Gly Asp Thr 80 
181 ATT TCA GTG GCC ATA GAC GTA ACG AAC GTC TAT ATT ATG GGA TAT CGC GCT GGC GAT ACT 240 
81 Thr Tyr Phe Phe Asn Glu Ala Ser Ala Thr Glu Ala Ala Lys Tyr Val Phe Lys Asp Ala 100 
241 ACC TAT TTT TTC AAC GAG GCT TCT GCA ACA GAA GCT GCA AAA TAT GTA TTC AAA GAC GCT 300 
101 Met Arg Lys Val Thr Leu Pro Tyr Ser Gly Asn Tyr Glu Arg Leu Gin Thr Ala Ala Gly 120 
301 ATG CGA AAA GTT ACG CTT CCA TAT TCT GGC AAT TAG GAA AGG CTT CAA ACT GCT GCA GGC 360 
121 Lys lie Arg Glu Asn lie Pro Leu Gly Leu Pro Ala Leu Asp Ser Ala lie Thr Thr LeU 140 
361 AAA ATA AGG GAA AAT ATT CCG CTT GGA CTC CCT GCT TTG GAC AGT GCC ATT ACC ACT TTG 420 
I 
141 Phe Tyr Tyr Asn Ala Asn Ser Ala Ala Ser Ala Leu Met Val Leu lie Gin Ser Thr Ser 160 
421 TTT TAC TAC AAC GCC AAT TCT GCT GCG TCG GCA CTT ATG GTA CTC ATT CAG TCG ACG TCT 480 
I 
161 Glu Ala Ala Arg Tyr Lys Phe lie Glu Gin Gin lie Gly Lys Arg Val Asp Lys Thr Phe 180 
481 GAG GCT GCG AGG TAT AAA TTT ATT GAG CAA CAA ATT GGG AAG CGT GTT GAC AAA ACC TTC 540 
181 Leu Pro Ser Leu Ala lie lie Ser Leu Glu Asn Ser Trp Ser Ala Leu Ser Lys Gin lie 200 
541 CTA CCA AGT TTA GCA ATt ATA AGT TTG GAA AAT AGT TGG TCT GCT CTC TCC AAG CAA ATT 600 
201 Gin lie Ala Ser Thr Asn Asn Gly Gin Phe Glu Ser Pro Val Val Leu lie Asn Ala Gin 220 
601 CAG ATA GCG AGT ACT AAT AAT GGA CAG TTT GAA AGT CCT GTT GTG CTT ATA AAT GCT CAA 660 
221 Asn Gin Arg Val Thr lie Thr Asn Val Asp Ala Gly Val Val Thr Ser Asn lie Ala Leu 240 
661 AAC CAA CGA GTC ACG ATA ACC AAT GTT GAT GCT GGA GTT GTA ACC TCC AAC ATC GCG TTG 720 
241 Leu Leu Asn Arg Asn Asn Met Ala *** 249 
721 CTG CTG AAT AGA AAC AAT ATG GCA TAG 747 
i 
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Fig. 1.1 The DNA sequence and amino acid sequence of 
TCS. 
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Fig. 1.3. Superimposition of TCS and ricin. Yellow and 
red lines represent a-backbone of TCS and riciti A-chain 
respectively. 
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1.1.2 Biological properties 
TCS is a type I ribosome-inactivating protein (RIP). Type I RIPs are 
single chain basic proteins of molecular weight of 26-30kDa. They are 
potent itihibitors of protein synthesis in cell free system. The ribosome-
inactivating activity of TCS is due to the N-glycosidase activity which 
： I 
specifically cleaves the N-glycosidic bond of A-4324 of 28s rRNA and 
releases the adenine residue (Etido and Tsimgi, 1988; Zhang and Liu, 
1992). It has been shown that the removal of A-4324 by ticin interferes 
with EF-1 (elongation factor 1) and GTP-dependent aminoacyl-tRNA 
binding to ribosome as well as the EF-2-cataIysed GTP hydrolysis and 
translocation and hence disrupting the process of protein synthesis 
(Furutatii et ai, 1992). 
TCS elicits immune response such as the production of IgE and IgG 
(Ng et al, 1992; Xii et ai， 1992) and hence limits its usefulness in clinical 
treatment. Some of its adverse reactions have been found in some practices 
in the induction of abortion and the treatment of AIDS after multiple 
administration of TCS to the patient. They include local inflammatory 
reaction, flu-like syndromes such as fever and tnyelalgias, and in extreme 
cases, fatal anaphylactic reaction (Lu and Jin, 1989 ； Kahn et al., 1990; 
Ferrari et a!., 1991). The anaphylactic reaction may be due to the 
activation of complement by TCS via the alternative pathway (Chen and 
Ma, 1993). 
5 
� 1 . 2 Structure of Antigens 
Since this study concerns with the investigation of the antigenic 
determinants of TCS, some basic information on the antigenic 
detenninants will be introduced. 
• 1 
The antigenic specificities of a protein reside in restricted areas of 
the molecule known as antigenic detenninants or epitopes, and are 
recognized by the combining sites or paratopes of certain immutioglobulin 
molecules (Van flegenmortel, 1991). Epitopes were originally classified as 
either sequential of cotifoitnational, however recently all epitopes are 
considered to be conformational but are classified as being either 
continuous or discontinuous. Continuous epitopes are defined as any short 
linear peptide fragments of the antigen that are able to bind to antibodies 
raised against the intact protein. Discontitiuoiis epitopes are epitopes made 
up of residues in the proteiti that are not continuous in sequence but are 
brought together by the folding of the polypeptide chain (Van 
Regenmortel, 1991). Fig. 1.4 explains the difference between continuous 
and discontinuous epitopes recognized by the immunoglobulin. Epitopes 
may also be classified as structural or functional (Van Regenmortel, 1991). 
Structural epitopes refer to the amino acid residues that are involved in the 
contact of immunoglobulin and these epitopes are usually found out by X-
ray crystallography of the antigen-antibody complex. Functional epitopes 
refer to the amino acid residues that are critical in the binding between the 
antigen and the antibody. These epitopes are usually found out by cross-
reactivity binding between the antigenic peptide and the antibody or by site 
directed mutagenesis of amino acid residues in the protein. Usually 
structural epitopes contain more amino acid residues than the flmcttonal 
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Fig. 1.4. Schematic representation of two antibodies 
interacting with a continuous and a discontinuous epitope 
of a protein antigen. Contact residues are indicated as 
solid circles (adopted from Van Regenmortel, 1991). 
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Many investigations have been done in order to find the essence of 
epitope on ptoteiii. However, up to now only some general characteristics 
of the epitope are ktiowii. Epitopes are generally on the surface of ptotein, 
more hydrophilic, more mobile and easily accessible (Westhof et a/.，1984; 
Hopp, 1986; Huang, 1990; Van Regeiimortel, 1991). In recent years X-ray 
diffraction studies of complexes of monoclonal antibody Fab fragments 
with their protein antigens have been done. These results may give a 
clearer picture about the antigenic sites on the protein. One example is the 
mitigenic sites on the lysozyme. Thtee epitopes have been analysed on its 
surface (Amit et a/., 1986; Padlan et at., 1989; Sheriff et al., 1987). In all 
cases，there is a large area of the protein surface (700 to 800A^) between 
15 to 22 amino acid residues. All epitopes identified by X-ray 
crystallography so far ate clearly discontinuous. The epitopes recognized 
by the anti-lysozyme D1.3 and HyHel-5 antibodies consist of two stretches 
of the lysozyme polypeptide chains (residues 18-27 and 116-129 for Dl.3， 
and 41-53 and 67-70 for HyHel-5), whereas the lysozyme HyHEL-10 
epitope consists of the exposed surface of a helix (residues 88-99) together 
with residues from several lysozme segments (residues 15-16, 20-21, 63, 
and 74-75). All of these epitopes are on the surface of the protein, more 
mobile and easily accessible. 
h i Methods Used for the Mapping of Antigenic Sites on the Protein. 
Most of our knowledge conceniirtg the location of epitopes in 
proteins is by studying the antigenic cross-reactivity between the 
immunoglobulin and peptide fragments of the antigen. The following 
section simunarizes some common approaches for mapping the antigenic 
sites on the ptotein. 
8 
X-ray crystallography 
The first method of epitope mapping is the X-ray crystallography of 
the antigen-antibody complex. This method can find the structural epitopes 
of a protein and gives the clearest information on the epitopes of the 
protein. However it is not easy to produce the crystal of the antigeti-
antibody complex. Therefore only a small number of epitopes have been 
defined by this approach. 
Cross-reactivity between synthetic peptide and immunoglobulin 
Another method of epitope mapping makes use of the techniques of 
synthetic peptide. For example, Geysen et al (1984) reported the use of 
synthetic peptide to probe for epitopes of a viral antigen. Hundreds of 
peptides (6 amino acids in length) which correspond to different region of 
the protein were synthesised and supported in a solid phase. These 
peptides were then analysed by enzyme-linked immunosorbent assay 
(ELISA) to look for the present of antigenic site on them. From this 
approach they have identified a seven amino acid peptide to be the 
antigenic site of the protein. 
In another approach, antigenic site is predicted from cDNA 
sequence or amino acid sequence by atitigenicity prediction algorithms. 
Then the antigenic fragment predicted by the algorithm is synthesised. The 
peptide is then injected to the animal to elicit immune response and to 
produce anti-peptide antibodies. If these antibodies can cross-react with 
the normal protein, the concerned peptide sequence is one of the antigenic 
sites of the protein (Mahale et al., 1993). 
9 
In some cases the synthetic peptides are not injected into the animal. 
They are allowed to react with the antigen sensitive T cells，B cells or 
macrophages. Proliferation assays are then performed to see if the peptides 
can elicit cell proliferation activity. If the cells can proliferate in the 
presence of the peptide, this means that the peptide sequence is the 
antigenic site of the antigen recognized by the immunological cells (Wierz 
et al.，1992; Karate et al, 1990). 
The advantage of using synthetic peptide is that usually continuous 
epitopes can be easily probed by this approach. However the majot 
problem of this approach is that usually the degree of antigenic cross-
reactivity observed with small peptide is very low. 
Chemical modificatioit 
Biimens et al (1987) used the characteristic that antibody bound to 
protein antigens decreases the rate of chemical modification of amino acid 
residues located at the epitope. Therefore by comparing the degree of 
acetylation of 18 lysine and threonine residues in free and antibody bound 
horse cytochrome, they identified the epitopes on the protein. This method 
can be used to map for discontinuous epitope, however it is not easy to 





111 this method，the cDNA of the interested protein is fragmented 
randomly by endonuclease. The fragment is then subcloned into expression 
vector to produce an epitope library. The library is then screened by the 
corresponding antibody to find out the positive clone that contains the 
antigenic site. The antigenic site is then located by DNA sequencing of the 
positive clone (Banting et al., 1989). Nowadays, there is actually a kit 
provided from Novagen for this purpose. However intensive in vitro 
manipulation is required in this method. 
Site specific mutagenesis 
Site specific mutagenesis is used to mutate specific site of the 
cDNA. The antibody binding response toward wild-type protein and the 
mutants is compared. If a mutation results in the change of antibody 
binding, it is assumed that the mutated residue is involved in the structure 
of an epitope and hence the corresponding antigenic site can be located 
(Alexander et al., 1992). This method can be used to define the 
discontinuous and ftinctional epitopes up to several amino acids, however 
it is not easy to find the suitable region for mutagenesis. 
Deletion mutagenesis 
Deletion mutagenesis is done on cDNA of the interested protein by 
transposon mediated mutagenesis (Sedgwick et al., 1991) or by 
exonuclease III (Gross and Rohemann, 1990). The mutants are then 
analysed by corresponding antibody. Antigenic site of the protein will be 
progressively lost as the expressed sequences are shortened； The 
corresponding antigenic site can be located by DNA sequencing of the 
“ 
deletion mutants. This approach involves less in vitro manipulation but 
only the continuous epitope can be mapped by this method. 
Analysis of chemical or enzymatic cleavage product of the protein 
111 this method the interested protein is cleaved by chemical or 
enzymatic method. The product is then analysed for the presence of 
antigenic site with the corresponding antibody. The location of the 
fragment can be foiitid by analysing the protein sequence if the cleavage is 
specific in certain amino acid residues or by N-tenninal detenniiiation of 
the corresponding antigenic fragment (Morris, 1989; Man et al., 1991). 
This approach usually identifies a large antigenic fragment and further 
studies are required. 
One of the characteristics of the epitope mapping is that all of the 
methods required the knowledge of cDNA sequence or amino acid 
sequence of the interested protein. Moreover the methods described have 
merits and drawbacks. Usually more than one of the approaches are 
required in the study of the antigenic determinants of a protein. 
12 
1.4 Objective and Strategy of the Study of the Antigenic 
Determinants of TCS 
The present study is to find out the antigenic determinants of TCS. 
The TCS protein has been shown to be useful in a number of clinical 
treatment (for example abortion, anti-tumor and anti-HIV), however 
problems of hypersensitivity due to the immunological response toward 
TCS has been found. Up till now, the antigenic determinants of TCS have 
only been underly defined (Ke et al, 1988). If the antigenic determinants 
of TCS are knovm, in the future the protein can be engineered to minimize 
its immunological side effects. 
In this study the epitope mapping by transposon mediated deletion 
mutagenesis is followed (Sedgwick et al., 1991). This method has the 
advantages of little in vitro manipulation and able to locate the epitopes 
precisely. In transposon mediated deletion mutagenesis of the cDNA of 
TCS, transposon InlOOO is inserted randomly into an expression vector 
which contains the TCS cDNA sequence. Translational stop codons at 
both ends of Tn7000 results in the production of shortened TCS proteins. 
Mutants which have lost the epitopes can be identified by Western blotting 
with antibodies. The precise location of the antigenic site can be 
determined by DNA sequencing with the use of Tn1000 specific primers. 
Another approach of this study includes the use of proteolytic 
enzymes and cyanogen bromide to generate protein fragments from TCS 
protein. The fragments are then analysed by Western blotting to see which 
can interact with the anti-TCS antibody. The protein fragments which 
react with anti-TCS antibody are N-terminal sequenced and their size 
13 
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Chapter Two 
Materials and Methods 
2.1 Bacterial Strains Used 
The following table summarizes the bacterial strains of Escherichia 
coli used: 
Bacterial strain I Genotype Purpose in this study Source 
MH1345 F" deoCsrlr.TnlO recAl Donor cell in bacterial S.G. Sedgwick 
mating 
MH755 F srlr.TnlO recAl thr-1 Recipient cell in S.G. Sedgwick 
leu-6 thi-1 lacYl galK2 bacterial mating 
araJ4 xylI4 mtl-1 proA2 
his-4 argES rp13l (sx33 
DH5a For subcloning of Our laboratory 
F VendA 1 hsdRl mutant 





BL21 ( DE3 FompThsdSB(r -^m-^;anT7 RNA polymerase F.W. Studier 
pLysS) E. coli B strain) driven expression 
system 
15 
2.2 General Techniques 
2.2.1 Extraction of DNA by phenol/chloroform 
An equal volume of phenol/chloroform (1:1) was added to the mixture 
and mixed by gentle agitation. The mixture was then centrifuged at 12，000g 
(13，000rpm) for 5 minutes to separate the aqueous and organic layer. The 
aqueous layer was then transferred to a new microcentrifuge tube. The DNA 
was precipitated by ethanol. 
2.2.2 Ethanol precipitation of DNA 
0.1 volume of sodium acetate (3M pH5.2) and 3 volumes of ice-cooled 
100% ethanol were added to the DNA solution. The DNA was precipitated at 
- 7 0 � C for 30 min and was then pelleted at 12,000g (13，000rpm) for 15 
minutes at 4 � C . The pellet was then washed with 70% ice-cooled ethanol 
once and dried in a SpeedVac (Savavt Instruments Inc.) machine. The DNA 
pellet was then dissolved in suitable amount of water. 
2.2.3 Minipreparation of plasmid DNA 
This method was adopted from Sambrook et al. (1989) with minor 
modification. A single bacterial colony was inoculated into 5ml of LB 
medium (section 2.16.1) containing the appropriate antibiotic in sterilized 
universal bottle. The culture was incubated overnight at 37�C with shaking at 
250rpm. Bacterial pellet of 3ml culture was collected by centrifugation at 
12,000g (13,000rpm) for 5 min in a microftige. The supernatant was 
discarded, the pellet was re-centrifoged for one min and the last drop of 
16 
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bacterial broth was takeii out with a fine pipette. 0.3ml of PI buffer (section 
2.16.2) was used to resuspeiid the cells completely. Then 0.3ml of P2 buffer 
(section 2.16.2) was added and mixed immediately. The solution was allowed 
to stand at room temperature for 5 mm. 0.3ml of P3 buffer (section 2.16.2) 
was added and mixed immediately with gentle agitation. The cell debris and 
chromosomal DNA were removed by centrifligation at 12,000g (13，000rpm) 
for 15 miti in a microfuge. 0.9ml of supernatant was taken out carefttlly and 
added with 0.45ml isopropanol. The solution was kept on ice for 15 min and 
centrifuged for 15 minutes at 12，000g(13，000rpm). The pellet was washed 
with 0.5nil of 70% ethaiiol and dried by SpeedVac. The plasmid was 
dissolved in 30^1 of water and stored at -20�C for later assay. 
2.2.4 Preparation of plasitiid DNA using Qiagen pack 100 Cartridge 
This method was modified from the Qiagen Application Protocol (4th 
Edition). A single colony was inoculated into 400ml of LB medium 
containing the appropriate antibiotic. The culture was incubated overnight at 
370c with shaking at 250rpm. The bacteria were collected by centrifiigation 
at 4，000g (5,000rpm) for 5 min at 4 � C (Beckman J2-21 CentrifUge with JA-14 
rotor). The pellet was resuspended in 10ml PI buffer. After 10ml of P2 was 
added, the mixture was allowed to stand at room temperature for 5 min. Then 
10ml of P3 buffer was then added to the mixture and mixed immediately but 
gently. The mixture was centriftiged at 4 � C for 30 min (15，000g rotor JA 20). 
The supernatant was removed promptly and recentrifiiged at 4 � C for lOltiin 
(15，000g) to obtain a particle-free clear lysate. A supernatant of about 30ml 
was collected. A Qiagen-pack 100 coliuim (Qiagen Inc.) was equilibrated 
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with 3ml ofQBT (750mM NaCl, 50mM MOPS，15% ethaiiol, pH7.0，0.15% 
Triton X-100). The flow was maintained by gravity. 1/3 volume (about lOml) 
of the supernatant collected by centrifugatioii was applied to the column. The 
column was then washed with 10ml QC (l.OM NaCl, 50mM MOPS，15% 
ethaiiol, pH7.0). The plasmid DNA adsorbed onto the column was eluted by 
passing through 5ml of QF (1.25M NaCl, 50niM MOPS, 15% ethanol, 
pH8.2). The above procedure was repeated twice to purify the plasmid DNA 
in the remaining supernatant. 
- 1 ' 
The plasmid DNA eluted from the above steps was recovered by 
precipitation with 0.7 volumes of isopropanol. The mixture was allowed to 
incubate on ice for 15 min and then the DNA was recovered by centrifogatioti 
at 12，000g (13，00rpm) for 20 min at 4 � C . The pellet was washed with 70% 
ethanol and dried by SpeedVac. The DNA was dissolved in 200^1 of water 
and stored at -20°C. 
2.2.5 Preparation of plasmid DNA using Magic™ Miiiipreps DNA 
Purification kit from Promega 
The following procedure is based on the Technical Bulletin provided 
by the Purification kit. A single colony was inoculated into 5ml of LB 
medium containing the appropriate antibiotic in a universal bottle. The culture 
was incubated overnight at 37�C with shaking at 250rpm. Bacterial pellet was 
collected by centrifugation at 12，000g (13,000rpm) for 5 min m a microfuge. 




added arid the tube was inverted several times to mix the solution. 200|il of 
P3 was added and the mixture was mixed by gentle agitation. Cell debris and 
chromosomal DNA were removed by centrifugation at 12，000g (13，000rpm) 
for 15 min in a microftige. The supernatant was transferred to a new 
microcentrifuge tube. 1ml of the Magic^^ Minipreps DNA Purification resin 
was added to the supernatant and the mixture was mixed by inverting the 
tube. A MagicTM Minicolutnn was prepared by connecting the coluim to a 
3ml disposable syringe with its plunger removed. The resin/DNA mixture was 
pipetted into the syringe barrel. The syringe plunger was inserted slowly and 
gently to push the slurry into the Minicoluran. Then the colimin was washed 
with 2ml of Column Wash Solution. Then the Minicoluirin was transferred to 
a new 1.5ml microceiitriftige tube and centrifiiged for 20 sec at 12，000g 
(13,000ipm) in a microfuge to dry the resin. The Minicolumn was then 
transferred to a new microcentrifiige tube and 50…of water was applied to 
the Minicolumn. After incubation for 1 min, the Minicolumn was centrifiiged 
for 20 sec at 12,000g (13,000rpm) to elute the DNA. The plasmid was stored 
at -20�C for later used. 
2.2.6 Preparation and transformation of Escherichia coli competent 
Cells 
The following method was adopted from Sambrook et al (1989) with 
modification. Escherichia coli cells of the concerned strain was streaked 
directly from a frozen stock onto the surface of an � plate (section 2.16.1). 
The plate was incubated overnight at 37�C and single colony from the plate 
was transferred to 5ml � medium (section 2.16.1). The culture was 
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incubated at 37�C with shaking until a D . _ reached about 0.3. The 5ml 
culture was then poured into 100ml (|)b medium and were continued to shake 
at 37�C for 2-3 hrs until O.D._ was about 0.45. The culture was then 
incubated on ice for 5 min. The bacterial cells were collected by 
centrifiigation at 4,000g (5,000rpm) for 10 min at 4 � C (Beckman J2-21 
Centrifuge with JA-14 rotor). After standing the tubes in an inverted position 
for 1 min to remove the last traces of medium, the pellet was resiispended in 
40 ml ofTfbl (30niM KAc, lOOmM RhCh, lOmM CaCb, 50mM MnCh and 
15% glycerol). The cells were incubated on ice for 5 min. Then the cells were 
collected by centrifiigation at 4,000g for 10 min at 4 � C (Beckman J2-21 
Centrifuge with JA 20 rotor). The supernatant was discarded and the cell 
pellet was resuspended in 4ml of Tfbll (lOmM MOPS, 75mM CaCl】，lOmM 
RbCl2 and 15% glycerol, adjust pH to 6.5 with KOH). The cells were kept on 
ice for 15 min aild the competent cell suspension was dispensed into aliquots 
of200|il each. The aliquots were frozetied in liquid nitrogen and stored at -70 
OC until use. 
For the transformation of the competent cells, the cells were put on ice 
until just thawed and about lOOng of DNA was added, and mixed gently. 
The tube was left on ice for 30 min and then heat shocked at 42 ^C for exactly 
90 sec. The tube was then immediately returned to ice for 2 min. Then 4 
volumes of LB medium was added into the tube and incubated at 37 ()C for 50 
mill with constant shaking to allow the bacteria to recover and to express the 
antibiotic resistance marker encoded by the plasmid. After the incubation, 50-
lOO i^l of the transformed culture was spreaded onto a LB agar plate with an 
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appropriate antibiotic. When the liquid had been absorbed, the plates were 
inverted and incubated at 37 ^C overnight. 
2.2.7 Agarose gel electrophoresis of DNA 
The agarose gel was prepared with 0.8-1.2% (w/v) agarose (BioRad) 
dissolved in Ix TAB or Ix TBE (section 2.16.3) buffer containing 0.5昭 
ethidium bromide/ml. Suitable amount of DNA sample was adjusted by 
diluting with water. 6x gel-loading buffer (section 2.16.3) was added to the 
DNA sample so that the final concentration of the loading buffer was Ix. The 
sample was loaded into the well and electrophoresis was performed at 
constant voltage of 80V in a gel tank containing Ix TAB or TBE (section 
2.16.3). After electrophoresis was finished, DNA was visualized on a 
Spectroline Model TC-302 UV Transilluminator (302iim) and then 
photographed with a Polaroid MP-4 instant camera and Polaroid 667 instant 
film through a HOYA R(25A) red filter. 
2.2.8 Restriction enzyme digestion of DNA 
Digestion of DNA was carried out in a suitable volume depending on 
the amount of substrate. A suitable amount of restriction enzyme and the 
appropriate buffer was added to the substrate as suggested by the supplier. 
The reaction mixture was incubated at 3 7 � C for 2-3 hr. After digestion, the 




2.2.9 Purification of DNA fragment from agarose gel using Gene 
Clean® kit 
The following method was suggested by the supplier. Either TAB or 
TBE was used as electrophoresis buffer. After agarose gel electrophoresis as 
stated in section 2.2.5, the gel was observed under UV illumination. The band 
containing the desired DNA was cut out from the agarose gel by a razor 
blade. The weight of the gel slice was measured and 3 vol of 6M Nal solution 
was added. If TBE had been used as buffer for electrophoresis, 2.5 vol of 
TBE modifier was added. The mixture was incubated at 55 ()C until the gel 
slice was melted completely. Then 5-10|LI1 of Glassmilk® silica matrix was 
added. The mixture was then kept on ice for 15 min with occasional shaking. 
The suspension was centrifuged in a microfiige at I2,000g (13,000rpm) for 1 
min. The pellet was washed with 0.7ml of NEW WASH solution. The 
washing procedure was repeated for two more times and the NEW WASH 
solution was completely removed by a fine pipette tip. The washed pellet was 
resuspended in 5-10|LI1 of water and incubated at 5 5 � C for 5 min to elute the 
DNA fragment. The supernatant containing the DNA was recovered by 
centrifugation in a microfuge at 12,000g (13,000rpm) for 1 min. The above 
DNA eluting procedure was repeated once and the total supernatant 
containing the DNA was pooled together and assayed by agarose gel 
electrophoresis to estimate the amount of DNA fragment recovered. 
2.2.10 Ligation of insert into vector 
The following method was modified from the suggestion of T4 ligase 
supplier, New England Biolabs Inc., which supplied us the T4 DNA ligase. 
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50ng of linearized vector, 20ng of insert, l^il of lOx ligase buffer (0.5M Tris-
HCl pH 7.8，O.IM MgCl2, O.IM dithiothreitol, lOitiM ATP，250^lg BSA) and 
of T4 DNA ligase (1 Weiss unit) were mixed with water in a 1.5ml 
microcentrifiige tube to a final volume of 10^1. The reaction mixture was 
incubated overnight at 16 o � . 
2.2.11 Rapid screening for the presence of plasmid by direct lysis 
of the bacterial colony 
The following method was modified according to Sanlbrook (1989). 
After transforniatioii, single colony was picked by sterilized toothpick and 
transferred to fresh LB agar plate with appropriate antibiotics. Bacterial 
colony was allowed to grow to 2-3mm in size. The bacterial cells were then 
transferred by a sterilized toothpick to the well of a 96-well plate which 
contained 20^il of the lysis buffer(50mM NaOH, 0.5% SDS，5mM EDTA and 
0.025% bromocresol green). The use of 96-well plate allowed the screening 
of large numbers of bacterial colonies at one time. The 96-"Well plate was 
sealed and incubated at 6 8 � C for 45 min. The mixture was then loaded to a 
0.7% TBE agarose gel without the addition of ethidium bromide and the two 
ends of the gel were allowed just touching the running buffer. When the 
mixture had migrated into the gel, more TBE buffer was added to cover the 
gel. After electrophoresis, the gel was stained by submerged in 0.5^lg/ml of 
ethidium bromide solution for 45 min. After staining. The gel was 





2.2.12 SDS"Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
All SDS-PAGE were tun with the Mini-Protean II electrophoresis cell 
(BioRad). The cell was assembled according to the manufacturer's 
instructions. 
Running gel, 12%, 15% and 20% were prepared as follow: 
Gel percentage 12% 15% 20% 
Water 1.6ml � . l m l 0.6ml 
30% acrylamide 2.0ml 2.5ml 3.0ml 
1.5M Tris(pH8.8) 1.3ml 1.3ml 13ml 
10% SDS 50|il 50|il 50nl 
10% ammonium persulfate 50f.il 50\.i\ 50|al 
TEMED 2 … 2^1 2 0 
3m\ of the running gel solution was pipetted into the gap between the 
glass plates. 200^1 of isopropaiiol was added to keep the mixture out of 
atmospheric oxygen which affected the polymerization reaction and to 
remove air bubbles on the surface of the mixture. The gel was allowed to 
polymerize for 30 min. Then isopropanol was discarded and the gel was 
rinsed with water. 
Stacking gel (3%) was prepared as follow: 
Water 1.4ml 
30% acrylamide 0.33ml 
l .OMTris (pH6.8) 0.25ml 
10% SDS 20… 




2ml of stacking gel mixture was pipetted into the gap between the glass 
plates and the comb was inserted. 15 min was allowed for the polymerization 
of the stacking gel. 
The volume of protein samples were adjusted to with water and 
15^1 of 2x SDS gel loading buffer was added. The samples wete denatured 
by boiling in water for 30 min and loaded to the wells. The gel was run at 
30mA constant current until the bromophenol blue reached the bottom of the 
running gel. The Mini-gel was disassembled and the gel was removed for 
staining or to perform Western blot. 
2.2.13 Staining of protein in polyacrylamide gel 
After electrophoresis the gel was immersed in 100ml staining solution 
(0.15% (w/v) Coomassie Brilliant Blue R-250, 31.25% (v/v) ethanol, 10% 
(v/v) acetic acid) for 1 hour. The gel was destained in destainitig solution 
(25%(v/v) ethanol, 8% (v/v) acetic acid) for overnight. 
2.2.14 Western blot detection of TCS 
After electrophoresis，the stacking gel was removed and the running 
gel was immersed in transfer buffer (section 2.16.5) for 5 min. The size of the 
running gel was measured. Six Whatman 3MM filter papers and one 
tiitrocellulose filter (Amersham Hybond-C) of the same size as the nmning gel 
was cut out. The 3MM filter paper and nitrocellulose filter were wetted with 
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transfer buffer. The semi-dry electroblotter (BioRad) with the gel, 3MM filter 
paper and nitrocellulose filter were set up as follow: 
Electroblotter -ve 
3x 3MM filter paper 一-— 
I 
NC filter 
O O O W O W M W O W W W M W O W W O W W O W O M O O W W W M W M O W W O O e W O O W W W O O O O W M O W 
Running gel 
� 3x 3MM filter paper 
Electroblotter +ve 
A constant current of 0.8mA per cm� of nitro-celliilose filter was applied for 1 
hr. ProtoBlot® Immunoscreening system from Promega was used for 
immunodetection of TCS. The following method was recommended by the 
supplier. After electroblottiiig, the nitrocellulose filter was immersed into 
10ml of TBSTB (section 2.16.5) for 30 min. TBSTB was then discarded and 
10ml of primary antibody (1:500 anti-TCS antibody) in TBSTB was added. 
The primary antibody was incubated for 2 hr at room temperature with 
continuous swirling. The filter was then washed repeatedly for 3 times with 
20ml of TEST (section 2.15.5) at 3 min each. 10ml of anti-rabbit IgG or anti-
mouse IgG antibody conjugated with alkaline phosphatase (1:7500 in 
TBSTB) was added and the filter was incubated with swirling at room 
temperature for 1 hr. The filter was then washed repeatedly for 3 times with 
20ml of TEST at 3 min each. The filter was blotted dry with paper towels and 
incubated in color development solution (AP buffer) prepared as follow: 
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AP buffer (seection 2.15.5) 10ml 
NBT substrate (50mg nitro blue 66\x\ 
tetrazolium /ml in 70% 
dimethylformamide) 
BCIP substrate (50mg 5-bromo-4- 33|.il 
cWoro-3-indoly丨 phosphate /ml in 70% 
dimethylformamide) 
The solution was swirled until color developed. When the color had 
developed to the desired intensity, the reaction was stopped by rinsing in 
water for several tiines. The filter was then air-dried for long term storage. 
2.2.15 Autoradiography 
Kodak X-OMAT AR diagnostic film was used for detection of DNA 
sequences. Films were exposed in a Kodak X-Omatic cassette at -70 ^C for 
overnight to one week. Films were developed with 15% Kodak X-ray 
developer for 5 min，fixed with 15% Kodak X-ray fixer for 5 mm and rinsed 
with tap water for 5 min. 
2.3 Production of Recombinant Anti-TCS Fab Fragment 
2.3.1 Cloning and screening of the recombinant anti-TCS Fab fragment 
The cloning and screening of the recombinant monoclonal anti-TCS 
Fab fragments were done by Ms. X. B. Li, an academic visitor from China. 
The following is a brief summary. Ms. Li used an Immunozap™ Cloning Kit 
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from Stratacyte to clone the genes. Mouse was first immunized with TCS by 
Dr. C. C. Wong and the spleen was collected for extraction of inRNA. cDNA 
was synthesised using mRNA as template and PCR reaction for light chain 
and heavy chain genes. The PCR products were then cloned into the phage 
vector to produce a light chain library and a heavy chain library. Then the 
light chain library and the heavy chain library were ligated at random to 
produce a Fab phage library. labelled TCS was used to screen for 
positive Fab clones. Forty two positive clones were saved in phage stock and 
stored at 4^C for the later expression of Fab fragment. 
2.3.2 Expression of recombinant anti-TCS Fab fragment 
In vivo excision of phagemid plasmid from the phage vector 
The following procedures were based on the I m H i u n o z a p ™ Cloning kit 
manual. Before the expression of Fab fragment, in vivo excision was done to 
allow cloned insert to be 仕ansformed to a convenience plasmid system. First 
of all, 200[i\ of XLl-Blue cells with 0 D _ = 0.5, 200^1 of the phage stock 
that contained the Fab gene and l|il of the R408 helper phage was mixed in a 
1.5ml conical tube. The tube was then incubated at 3 7 � C for 15 min. Then 
5ml of 2x YT medium was added and incubated for 3 lir at 37 ^C with 
shaking. After incubation the tube was heated at 70 ()C for 20 min, and then 
centrifiiged for 5 min at 4000g in a bench top centrifuge. The supernatant was 
then transferred to a sterilized tube. 20|LI1 of the supernatant was added with 
200^1 of XLl-Blue cell ( 0 D _ = 0.5) in a 1.5ml microcentrifiige tube and 
incubated at 3 7 � C for 15 min. l|il to 100^1 of the mixture was plated onto LB 
plate containing 30|Lig/ml ampicillin and incubated overnight at 37 
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Overnight colony was streaked to new LB plate containing 30jig/ml 
ampicillin and glycerol stock was made for long term storage. 
Expression of the Fab fragment 
Overnight colony which contained the Fab gene was inoculated into 
5ml of LBA broth (LB broth with 50|Lig ampicillin/ml). The culture was 
incubated overnight at 3 7 � C with vigorous shaking. The culture was then 
diluted 50-fold and transferred to a 500ml conical flask. The culture was to 
shaked continuously until the ODeoo was about 0.6. Then IPTG was added to 
a final concentration of ImM. The culture was then shaked continuously for 
10 lir and the supernatant was collected by centrifiigation at 4 ()C for 20 min at 
7,000g (8,000rpm Beckman J2-21 Centrifuge with rotor JA 20). The 
phagemid supernatant was then saved for further concentration. 
The supernatant was concentrated by 500ml Amfcon Ultra-filtration 
cell. 500ml of the supernatant was concentrated to 10ml and then dialysed 
against IL of TEST overnight at 4 � C . Bovine serum albumin and sodium 
azide were added so that the final concentration were 1% and 0.03% 
respectively. The aiiti-TCS Fab fragment was then stored at 4 T for later 
used. 
2.4 Construction of Deletion Library of pET58210 by Transposon 
Mediated Mutagenesis 
The procedures were based on the work of Sedgwick (1991). 
pET58210, a T7 expression vector with the TCS cDNA, was transformed 
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into MH1345 donor competent cells and spreaded on LB A agar plate with 
50^ig thymine/ml to select for positive colony. MH755 recipient cells were 
streaked into a selective LBS agar plate (LB agar plate with lOO^lg/ml 
streptomycin). A single colony of the donor cells with pET58210 was picked 
into 10ml of LBA broth with 50|ig thymixie/ml and grew at 37�C with 
vigorous shaking. A single colony of the recipient cells was picked into lOml 
of LBS broth aiid grew at ?>TC vigorous shaking. 0.1ml of the overnight 
cultures of donor cells and recipient cells were inoculated in 10ml fresh LB 
broth with 50^ig thymine/ml, 50jig ampicillin/ml and lOOjug streptomycin/ml 
respectively. The above culture was grown to log phase and was collected by 
centrifugation at 4,000g for 5 min at room temperature (5,000rpm Beckmati 
J2-21 Centriftige with rotor JA 20). The cell pellet was washed twice with 
fresh pre-warmed LB broth . The donor and recipient cells were resuspended 
together in 10ml of fresh LB broth without any antibiotics. The cell mating 
mixture was transferred to a IL flask which had been pre-warmed to 3TC. 
After incubation at 37�C without shaking lor 1 hr, the cell mixture was 
collected by centrifugation at 4,000g for 5 min at room temperature 
(5,000rpm Beckman J2-21 Centrifuge with rotor JA 20) and washed twice 
with fresh LB broth. 10-100|il cell mixture was spreaded onto selective plates 
which contained 50明 ampicillin/ml and 100|ig streptomycin/ml. After 
overnight incubation at 37 T , single colony was picked by toothpick and 
spreaded on a fresh LBAS plate. The plate was incubated overnight at 37 V 
and saved for later PGR screening procedures. 
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2.5 PCR Insertion Mapping of the Transposon Inserted Clones 
Plasmid DNA of the positive clones were prepared as described in 
section 2.1.1. Two PCRs for each clone were set up to map the insertion site 
of the transposon. For the first reaction, pET forward primer, TnlOOO gamma 
and delta end primers were used. For the second reaction, primer B, TnlOOO 
gamma and delta primers were used. The primer sequences were shown as 
follow: 
1. pET forward primer 
AACGGTfTCCCTCTAGAAAT 
2. primer B 
AACGCGATGTTGGAGGT 
3. TnlOOO delta end primer 
AGGGGAACTGAGAGCTCTA 
4. Tn7 000 gamma end primer 
C A G C T A C A A C A T A C G A A A G 
The following method was based on Sambrook et al. (1989) with 
modification. Plasmids from the positive clone were used as template for 
polymerization. VenF'^ DNA polymerase and lOx amplification buffer were 
supplied by the New England Biolabs. 
All PCRs were done in 25 pi total volume with light mineral oil as 
overlay In Temptronic temperature cycler machine. The reaction mixture 
contained 2.5fxl of lOx amplification buffer, 4ILI1 dNTP mix (1.25inM of 
dATP, dCTP, dGTP，dTTP), 2.5^il o fpET forward (20|LIM) primer or primer 
B (20MM), 2.5|I1 of TnlOOO gamma primer and delta primer (20|LLM) and 0.5 
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U of V e n t ™ polymerase was added. Template (up to O.S^ig) was added to 
the reaction mixture. Water was added so that the final volume of the mixture 
was 25|LI1. 
Amplification was carried out under the following cycles: 
Cycle Denaturation Annealing Polymerization 
1st Cycle 3 minutes at 94T 1 minute at 55"C 1 minute at 72T 
2nd to 34th Cycle 1 minute at 94�C 1 minute at 55�C 1 minute at 72T 
35th Cycle 1 minute at 94T 1 minute at 55T 6 minutes at 72T 
After amplification, 12|il of the amplification mixture was taken out 
and added with 3^1 of 6x agarose gel loading buffer (section 2.16.3). The 
mixture was loaded to an agarose gel (section 2.2.7). After electrophoresis, 
photograph was taken to analyse for the positive clones. 
2.6 DNA sequencing of positive clones after the PGR insertion 
mapping 
Mutated pET58210 plasmid DNA with the transposon inserted within 
the TCS gene sequence were verified by DNA sequencing to locate the exact 
position of the transposon insertion site. TnlOOO gamma end primer 
(sequence shown at section 2.5) was used as primer and the double stranded 
plasmid DNA as template. 
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2.6.1 DNA sequencing reaction 
Sequencing reaction was carried out using Pharmacia T7 Sequencing 
kit. The following procedures were based on the manual provided by the 
supplier. Mutated plasmids DNA were prepared by Magic™ Miniprep 
(section 2.2.5). 2|Lig of plasmid DNA dissolved in 8|LI1 of water was used as 
template. 2|LI1 of 2M NaOH was added to the template and vortex gently to 
allow incubation at room temperature for 10 min. After denaturation of the 
t e m p l a t e， o f 3M sodium acetate (pH4.5) together with 7^1 of H2O was 
�•“'J' 
added to the mixture to neutralize the mixture. After mixing，60^1 of absolute 
ethanol was added to the mixture to precipitate the DNA. The mixture was 
stored at - 7 0 � C for 30 min and the DNA was collected by centrifiigation at 
12,000g (13，000rpm) for 20 min at 4 � C in a microfuge. The pellet was 
washed with 80^1 of ice-cool 70% ethanol and dried by SpeedVac. The dried 
pellet was then dissolved in lO^il of water and then 2 |LI1 of annealing buffer 
and 5\ig/m\ primer solution were added to the template solution. The mixture 
was incubated at 6 5 � C for 5 min and 37 "C for 10 min and at room 
temperature for 5 min. 3ii\ of labelling mix, 1 of dCTP (lOmCi/ml, 
>1000Ci/mmol, Amersham SJ304) and 2^1 of diluted T7 DNA polymerase 
(1.5umts/|il, diluted with enzyme diluting buffer) were added to the reaction 
mixture. The mixture was incubated at room temperature for 5 min. During 
incubation, 2.5jxl of A-’ G-, C-, and T- mix short was added to four labelled 
fresh microfuge tubes which had been prewarmed at 3 7 � C . After incubation, 
4.5^1 of the reaction mixture was added to each of the four prewarmed 
• I 
sequencing mixes. The four tubes were incubated at 3 7 � C for 5 min. Then 5^1 
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of stop solution was added to each tube. The mixture was then stored at -20 
0 � f o r DNA sequencing electrophoresis. 
2.6.2 DNA sequencing gel casting and electrophoresis 
All sequencing gels were run with Sequi-Gen® Nucleic Acid 
Sequencing Cell. The glass plate and the IPC (Intergral Plate/Chamber which 
is a bound glass plate and buffer chamber) were cleaned with distilled water 
and ethanol thoroughly. Then the surfaces of the glass plates which contact 
the gel was wiped with repel-silane (dimethyldichlorosilaiie solution 2%(w/v) 
ill 1,1,1-trichloroethane) using lint-free tissue paper. The unit was then 
assembled according to the manufacturer's instruction. 10ml of the 
acrylamide solution with the addition of 125|LI1 10% ammonium persulfate and 
50fil TEMED was used to seal the bottom gap between the glass plate and 
the IPC. After the sealing gel had polymerized, the unit was laid iii a tray so 
that the plate was inclined at an angle of about 20() . The remaining 90ml of 
acrylamide solution was added with 600^il 10% ammonium persulfate and 
50|LI1 TEMED. The gel was then poured into the gap between the glass plates 
and the IPC. The unit was then placed horizontally and a sharkstooth comb 
was inserted. The gel was allowed to polymerize for 1 hr. 
When the polymerisation was completed, the sharkstooth comb was 
inserted with the teeth just touching the gel boundary. The unit was then 
assembled onto the gel tank and the lower and upper buffer reservoirs were 
filled with Ix TBE buffer. The gel was pre-run at 40W for 30 min. Before 
loading, the samples were heated at 80"C for 2 min. After the urea at the 
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wells had washed away, 3^1 of sample was loaded into each well using 
sequencing pipette (Dmmmond). The gel was then nm at constant power 
40W to maintain a temperature of about 50�C. After the bromophenol blue 
tracking dye had just run to the bottom of the gel, electrophoresis was 
stopped and the sequencing cell was dissembled. The gel was then fixed in 
10% v/v acetic acid for 10 min. Then the gel was blotted onto a sheet of 
3MM Whatman filter paper. A piece of plastic wrap was used to cover the 
gel surface. The gel was dried in a gel dryer (BioRad) and exposed to an X-
'I' 
ray film (section 2.2.15). 
2.7 Computer Analysis of the DNA Sequence 
After DNA sequencing of the positive clones, the sequences were 
analysed using the computer programme DNASIS (Hitaclii). The sequences 
were compared with the TCS gene sequence to find out the TnlOOO insertion 
site and the orientation of the TnWOO. This iiiformatioii was then used to 
decide which subcloning procedures should be followed. 
2.8 Subcloning of the Positive Clone that Have Been Located by DNA 
Sequencing 
After DNA sequencing and computer analysis to find the exact location 
of the TnlOOO insertion site, the deleted TCS gene sequence was subcloiied 
by two methods depending on the orientation of the inserted Tn7 000. 
1 
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2.8.1 Subcloning of the mutated TCS gene sequence with the TnlOOO 
delta end facing the N-terminal of the TCS gene sequence 
Plasmid DNA with inserted TnlOOO delta end orientated to the N-
terminal of the TCS gene were prepared by Magic™ Miniprep (section 
2.2.5). 5|Lig of the plasmid DNA was cut by BamW I and Nco 1 (section 
2.2.8). The reaction mixture was than loaded to a TBE agarose gel with 
Lamda HinA III digested DNA and 123 bp ladder as markers. The size of the 
deleted TCS gene fragment visualized under UV after electrophoresis was cut 
and purified using GeneClean® kit (section 2.2.9). 
5|ig ofpETSc was cut by BamVi 1 and Nco I. The reaction mixture was 
then loaded to a TAE agarose gel and after electrophoresis, the 4.6kb 
fragment was purified using GeneClean® kit and was finally dissolved in 
20)il HiO. 
50ng of 4.6kb fragment of pET8c and 20ng of the deleted TCS gene 
fragment were ligated using T4 DNA Ligase (New England Biolabs) 
overnight at 1 6 � C (section 2.2.10). The ligation mixture (10^ll) was added to 
200|il of DH5a competent cells. Transformation was preformed as described 
in section 2.2.6. 
The transformed colonies were screened by rapid lysis (section 2.2.11) 
for the presence of insert in pET8c. Higher molecular weight plasmid DNA as 
compared to pET8c was prepared by Magic™ Miniprep (section 2.2.4). The 
plasmid DNA was then analysed by restriction digestion with Nco I and 
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Bamn I followed by agarose gel electrophoresis to confirm the insertion of 
the TCS gene fragment into the pET8c vector. 
2.8.2 Subcloniiig of mutated TCS gene sequence with the InlOOO 
gamma end facing the N-terminal of the TCS gene 
Plasmid DNA with the inserted InlOOO gamma end orientated to the 
N-termiiial of TCS gene was prepared by Magic™ Miniprep (section 2.2.5) 
and used as template for PGR reaction. A TnlOOO gamma end mutagenic 
primer was made with the addition of a BamW I site and was used as 
backward primer. The pET forward primer was used as forward primer 
(sequence shown at section 2.5). The primer sequence of the TnlOOO gamma 
end mutagenic primer was shown as follow: 
1. TnlOOO gamma end mutagenic primer 
BamW I site 
GCTATGGAICCACAGATGGGGAAACT 
All PCRs were done in a total volume of 50^1 with light mineral oil as 
overlay. The reaction mixture containing 5^1 of lOx amplification buffer, 8fxl 
dNTP mix (1.25niM of dATP, dCTP, dGTP, dTTP), 5fxl of pET forward 
primer ( 2 0 _ ) , 5|li1 of TnlOOO gamma end mutagenic primer (20^M) and lU 
of Vent™ polymerase was added. Mutated pET58210 plasmid was used as 
template and was added to the reaction mixture. Water was added so that the 
final volume of the mixture was 50|il. 
Amplification was carried out under the following cycles: 
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Cycle Denaturation Annealing Polymerization 
1st Cycle 3 minutes at 94�C 30 seconds at 55�C 30 seconds at 72�C 
2tid to 34th Cycle 1 minute at 94�C 30 seconds at 55�C 30 seconds at 72T 
35th Cycle 1 minute at 94�C 30 seconds at 55T 3 minutes at 72T 
After amplification, the DNA product was undergone phenol/ 
chloroform extraction and ethanol precipitation (section 2.2.1 & 2.2.2). The 
DNA product was then digested with Ncol and BamU I (section 2.2.8). The 
digested mixture was then loaded to TAB gel with Lamda Hind III digested 
and 123 bp as markers. The molecular weight of the amplified mutated TCS 
gene sequence was calculated and the corresponding fragment visualized 
under UV after electrophoresis was cut and isolated by GeneClean® kit 
(section 2,2.9). 
of pET8c was cut by Nco I and BamU I The reaction mixture was 
then loaded to a TAE agarose gel and after electrophoresis, the 4.6kb 
fragment was purified using GeneClean® kit and was finally dissolved in 
20|il H2O. 
50tig of 4.6kb fragment of pET8c and 20ng of the deleted TCS gene 
fragment were ligated using T4 DNA Ligase (New England Biolabs) 
overnight at 1 6 � C (section 2.2.10). The ligation mixture (lOfxl) was added to 
200^1 of DH5a competent cell. Transformation was preformed as described 
in section 2.2.6. 
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The transformed colonies were screened by rapid lysis (section 2.2.11) 
for the presence of insert in pET8c. Higher molecular weight plasmid DNA as 
compared to pET8c was prepared by Magic^^ Miniprep (section 2.2.4). The 
plasmid was then analysed by restriction digestion with Nco I and BamH I 
I 
followed by agarose gel electrophoresis to confirm the insertion of the TCS 
gene fragment into the pET8c vector. 
2.9 Construction of Deletion Mutants that Exclude the 21 Amino Acids 
in the N-terminal of TCS 
Plasmid DNA of mutant 4 and 308 was prepared by Magic™ 
Miniprep (section 2.2.5) and used as template for PCR reaction. A forward 
deletion primer was made with the addition of a Nde I site was used as 
forward primer. A TnlOOO gamma end mutagenic primer was made with the 
addition of a BamR I site and was used as backward primer (sequence shown 
at section 2.7.2). The primer sequence of the forward deletion primer is 
shown as follow: 
1. Forward deletion primer 
Nde I site 
GTTTTCCATATGAATCTGAGAAAAGCT 
All PCRs were done iii a total volume of SOjul with light mineral oil as 
overlay. The reaction mixture containing 5^1 of lOx amplification buffer，8^1 
dNTP mix (1.25mM of dATP, dCTP, dGTP, dTTP), 5|il of forward deletion 
primer, 5|LI1 of TnlOOO gamma end mutagenic primer and lU of Vent™ 
polymerase. Mutant plasmid was used as template and was added to the 
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reaction mixture. Water was added so that the final volume of the mixture 
was 50|il. 
The amplification was carried out under the following cycles: 
Cycle Denaturation Annealing Polymerization 
1st Cycle 3 minutes at 94T 20 seconds at 55�C 20 seconds at TTC 
2nd to 34th Cycle 1 minute at 94�C 20 seconds at 55T 20 seconds at 72T 
35th Cycle ‘ 1 minute at 94�C 20 seconds at 55�C 3 minutes at 72T 
After amplification, the DNA product was undergotie phenol/ 
chloroform extraction and ethanol precipitation (section 2.2.1 & 2.2.2). The 
DNA product was then digested with Ndel and BamH 1 (section 2.2.8). The 
digested mixture was then loaded to TAB gel with Lamda Hind III digested 
and 123 bp ladder as markers. The molecular weight of the amplified mutated 
TCS gene sequence was calculated and the corresponding fragment 
visualized under UV after electrophoresis was cut and isolated by 
GeneClean® kit (section 2.2.9). 
of pET3c was cut by Nde I and BamH I. The reaction mixture was 
then loaded to a TAB agarose gel and after electrophoresis, the 4.6kb 
fragment was purified using GeneClean® kit aiid was finally dissolved in 
2 0 _ 2 0 . 
I 
50ng of 4,6kb fragment of pET3c aiid 20iig of the deleted TCS gene 
fragment were ligated using T4 DNA Ligase (New England Biolabs) 
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overnight at 1 6 � C (section 2.2.10). The ligation mixture (lOjiil) was added to 
200|il of DH5a competent cell. Transformation was preformed as described 
in section 2.2.6. 
The transformed colonies were screened by rapid lysis (section 2.2.11) 
for the presence of insert in pET3c. Higher molecular weight plasmid DNA as 
compared to pET3c was prepared by Magic™ Miniprep (section 2.2.4). The 
plasmid was then analysed by restriction digestion with Nde I and BamH I 
followed by agarose gel electrophoresis to confirm the insertion of the TCS 
gene fragment into the pET3c vector. 
2.10 Overexpression of Mutated TCS Protein with the T7 RNA 
Polymerase Driven Expression System 
The subcloned plasmid DNA were then transformed into E, coli 
expression host BL21 (DE3, pLysS) to produce the deleted TCS protein by 
the T7 RNA polymerase driven expression system. Preparation of competent 
cells and transformation were preformed as stated in section 2.2.6. 
A single colony of BL21 (DE3，pLysS) containing the deleted TCS 
gene was inoculated in 20ml of M9ZB (section2.15.1) with lOO^g 
ampicillin/ml and 50^ig chloramphenicol/ml in a lOOml conical flask. The 
culture was grown at 37�C overnight with vigorous shaking. The culture was 
shaked continuously at 37 "C for 4-5 hr until O .D._ was about 0.8. 
Expression was then induced by adding isopropyltliio-P-galactoside (IPTG) 
to a final concentration of 0.4mM. The culture was grown at 37�C for 3 more 
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hr. The cells were collected by centrifiigation at 12,000g (13，000rpm) in a 
microflige for 10 min at room temperature. The cells were then stored at 
-20^C for later assay. 
2.11 Analysis of TCS Deletion Mutants by Western Blotting 
The expressed cell pellet was used directly for Western blot analysis. 
The cell pellet was first added with 0.4ml of sample buffer (50mM Tris 
pH6.8, 2mM EDTA, 1% SDS, 1% mercaptoethanol, 8% glycerol, 0.025% 
bromophenol blue). The cells were then sonicated for 10 sec atid denatured 
by boiling for 3 rain. 1 5 0 of the mixture was directly loaded to a 15% SDS-
P A G E for electrophoresis (section 2.2.12). After electrophoresis, Western 
blot was performed (section 2.2.14). Recombinant monoclonal anti-TCS Fab 
fragment (section 2.3)，classical monoclonal anti-TCS antibody and 
polyclonal anti-TCS antibody were used for the binding of deletion mutated 
TCS protein. 
2.12 Preparation of Recombinant TCS Protein 
Procedures of the work were based on Zhu et al. (1992). Expression 
vector containing recombinant TCS gene, pET582lO, was transformed into E. 
coli expression host, BL21 (DE3, pLysS). Preparation of competent cells and 
transformation were performed as described in section 2.1.6. A single colony 
of BL21 (DE3, pLysS) containing pET58210 was inoculated in 10ml M9ZB 
medium with lOO i^g ampicillin/ml and 50昭 chloramphenicol/ml. The culture 
was grown at 37�C overnight with vigorous shaking and then transferred to 
IL M9ZB with the same amount of antibiotics. The culture was grown at 
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3 7 T with vigorous shaking imtil 0 D _ 二 0.8 . The expression was then 
induced by adding isopropylthio-P^galactoside (IPTG) to a final concentration 
of 0.4mM. The culture was grown at 3TC for 3 more hr. The cells were 
collected by centrifugation at 4,000g (5,000rpm Beckman J2-21 Centriflige 
rotor JA-14) for 10 min at 4 � C . After the supernatant was discarded, the 
weight of the cell pelleted was measured. The pellet was resuspetided in 30 
ml of 50mM NaH2p04 (pH6.5) with O.lmM phenylmethysulfonyl fluoride 
(PMSF) and 0.1% (v/v) (3-mercaptoethaiiol. The suspension was sonicated for 
eight cycles (30 sec sonication and 30 sec cooling on ice) and was then 
centrifiiged at 15,000rpm for 30 minutes at 4 X：. The supernatant was 
collected and dialysed against SOmM NaH^PCli, pH6.5 at 4 ^C overnight. 
After dialysis，the supernatant was applied to a CM Sepharose CL-6B 
column (2.5 x 26cm) which had equilibrated with buffer A (50mM NaH2P04 
,pH6.5) and comiected to the BioRad Econo System. The flow rate was kept 
at 2 ml/mill. The column was washed with buffer A until OD280 of the eluant 
was less than 0.05. TCS was eluted by applying a 120ml 0 - 0.5 M NaCl 
gradient at a flow rate of 2ml/min. The peak was collected and dialysed 
against 2L buffer A overnight at 4�C. The column was then washed with high 
salt buffer and equilibrated with buffer A again. The dialysed solution was 
then applied to the CM Sepharose CL-6B column again with a flow rate of 
2tnl/mm. TCS was eluted by applying a 120ml 0 - 0.3 M NaCl gradient at a 
flow rate of 2ml/mm. The peak was collected and dialysed against 2L 
distilled water. The purified TCS was then snap-freezed in liquid nitrogen and 
lyophilized. The lyophilized protein was then stored at 4 T for later use. 
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2.13 Proteolytic and Chemical Cleavage of Recombinant TCS 
Three proteolytic enzymes and one chemical agent were used to cut the 
recombinant TCS into smaller peptides for epitope detection using Western 
blotting analysis. 
Proteolytic enzyme cleavage 
Alkaline protease (Promega), Endoprotease Lys-C (Promega) and Glu-
C (Promega) were used for the cleavage of recombinant TCS protein. The 
enzymatic cleavage reactions were done in a microcentrifuge tube with O.IM 
Xris-HCl pH8.0 and 0.1% SDS as reaction buffer. Protease was added so that 
protease : protein ratio was 1%. The digestion mixtures were incubated at 
370c for 90 min. The digested products were then analysed m 16.5% high 
resolution SDS-polyacrylainide gel (section 2.12). 
Chemical cleavage 
Cyanogen bromide was used for chemical cleavage of recombinant 
TCS protein. Img of cyanogen bromide and Img of recombinant TCS protein 
were dissolved in 300|LI1 of 50% Trifluoroacetic acid. The digestion mixture 
was incubated at room temperature for 6 hr with constant agitation. After 
incubation, the reaction was stopped by lyophilization. The lyophilized 





2.14 Tricine-SDS-16.5% Polyacrylairtide Gel Electrophoresis 
The following method was developed by Schagger and von Jagow 
(1987). 
Stock solution 
The stock solutions for gel electrophoresis are listed in the following 
tables: 
Buffer Tris (M) Tricine (M) ^ S D S (%) 
Anode 0.2 - 8.9" -
Cathode 0.1 0.1 8.25卜 0.1 
Gel buffer 3.0 - 0.3 
a Adjusted with HCl 
b No correction of the pH，which was around 8.25 
Acrylamide- Percentage Percentage 
bisacrylatnide acrylamide bisacrylamide 
mixture (w/v) (w/v) 
49.5% T, 3% C 48 " 
49.5% T, 6% C 46.5 3.0 
丁 二 total percentage of acrylamide and bisacrylamide 
C = crosslink percentage of the acrylamide gel 
Preparation of glass plates for gel casting 
The surfaces of a pair of glass plates (20 x 15.5cm，17 x 15.5cm) were 
cleaned with distilled water and ethaJiol thoroughly. Three 0.7mm thick 
spacers were placed in between. The plate sandwich was fixed by using six 
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metal clips. Finally the three edges of the sandwich were sealed with 1% 
agarose. 
Gel casting 
The compositions of separating, spacer and stacking gel are shown in 
the following table: 
Stacking gel Spacer gel Separating gel 
4% T, 3% C 10% T，3%C 16.5% T, 6% C 
49.5% T, 3% C solution 1 ml 6.1 ml -
49.5% T, 6% C solution - - 10 ml 
Gel buffer 3.1 ttil 10 ml 10 ml 
Glycerol - 一 4.3tnl 
Added water to a final 12.5 ml 30 ml 30 ml 
volume of 
Degas of the gel solutions were not required 
The separating gel and the spacer gel were polymerized together in the 
glass plate. Because the presence of glycerol in the separating gel, the two gel 
solutions did not mix together in the process of adding the gel solution. With 
the addition of 150jxl 10% ammonium persiilfate and IS^il TEMED, the 
separating gel solution was first poured between the gap of the glass plate 
sandwich prepared iii the previous step. Then the spacer gel solution with the 
addition of 100^1 of 10% ammonium persulfate and 10|il TEMED was 
poured slowly between the gap of the glass plate sandwich. Then 1ml of 
isopropanol was added to keep the solution from atmospheric oxygen and to 
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remove air bubbles. The separating gel and spacer gel were allowed to 
polymerized together for 30 min. After the separating and spacer gel had 
polymerize, the isopropanol layer was removed. The stacking gel with the 
addition of lOOiml 10% ammonium persulfate and 10…TEMED was poured 
and the comb was inserted to the gap between the glass plate. 
Electrophoresis 
When the polymerization was completed, the comb was removed and 
the wells were washed thoroughly with water to remove any trace of 
unpolymerized monomer. The gel plate sandwich was then assembled onto 
the gel tank. The upper buffer reservoirs were filled with cathode buffer and 
the lower buffer reservoir was filled with anode buffer. The protein samples 
with the addition of 2x SDS-PAGE sample buffer (section 2.15.4) and 
denatured at 100�C for 3 min were loaded into wells. Electrophoresis was 
started at 30V constant voltage for 1 hr and then 15mA constant current for 
24 hr. After electrophoresis, the glass plates were dissembled and the gel was 
used for staining of Western blotting. 
Fixing, staining and destaining 
The protein bands were fixed in a solution containing 50% methanol 
and 10% acetic acid for 30 min before they were stained with 0.025% 
Coomassie Brilliant Blue R-250 in 10% acetic acid for 1-2 hr. The gel was 
then destained in 10% acetic acid for 2 hr. 
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2.15 Electroblotting Using Polyvinylidene Difluoride Membrane (PVDF) 
for N-terminal Determination 
After electrophoresis (section 2.12)，the stacking and spacer gels were 
removed atid immersed in electrobuffer (200ml lOx CAPS (section 2.15.7) + 
200ml methanol + 1600ml H2O). The size of the separating gel was 
measured. Six Whatman 3 MM filter papers and one PVDF (Millipore 
Immoblin-P PVDF) of the same size as the running gel was cut out. The 
3 m m filter papers and PVDF membrane were wetted with electrobuffer. The 
semi-dry electroblotter (BioRad) with the gel，3MM filter papers and PVDF 
membrane were set up as follow: 
Electroblot ter -ve 
3x 3 M M filter paper 
— p v n F 一 
Separat ing gel 
3x 3 M M filter paper 
E lec t rob lo t t e r -ve 
A constant current of 0.8mA per cm^ of PVDF membraiie was applied 
for 1 hr. After blotting, the PVDF membrane was removed and rinsed with 
deionized water. The PVDF membrane was then stained with the staining 
solution (0.15% (w/v) Coomassie Brilliant Blue R-250, 31.25% (w/v) 
ethanol, 10% (v/v) acetic acid ) for 5 miti. The PVDF membrane was then 
destained in 
destaining solution (25% (v/v) ethanol, 8% (v/v) acetic acid) for 
I hr. The PVDF was then blotted dry and the interested protein band was cut 
out for N-terminal determination. 
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2.16 Reagents and Buffers 
2.16.1 Media for bacterial culture 
LB (Luria-Bertani medium) 
lOg bacto-tryptone 
5g bacto-yeast extract 
lOgNaCl 
-i' 
The solution was adjusted to pH7 with lOM NaOH and the volume 
was made up to 1 litre with water. The medium was sterilized by 
autoclaving for 20 minutes at 15 Ib/sq. in. pressure on liquid cycle. 
(|)b medium 
5g bacto-yeast extract 
20g bacto-tryptone 
lO.2gMgSO4.7H2O 
The volume was made up to 1 litre with water and the medium was 









The volume was made up to 1 litre with water. The medium was 
sterilized by autoclaving for 20 minutes at 15 Ib./sq.in pressure on 
liquid cycle. 20 ml of 20% glucose and 1 ml of MgS04 was added to 




lOg bacto-yeast extract 
lOg bacto-tryptone 
The volume was made up to 1 litre with water and the medium was 
sterilized by autoclaving for 20 minutes at 15 Ib./sq.in. pressure on 
liquid cycle. 
Media containing agar 
Liquid media were prepared according to the recipes given above. Just 
before autoclave, 15g of bacto-agar was added to 1 liter liquid medium. 
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2.16.2 Reagents for preparation of plasmid DNA 
PI (stored at 4"C) 
5mM Tris-Cl (pH8.0) 
lOmMEDTA 
100|ig/ml RNase A 
P2 (stored at RT) 
0.2M NaOH 
1% SDS 
P3 (stored at RT) 
2.55 M potassium acetate (pH4.8) 
2.16.3 DNA electrophoresis buffers 




TBE (Tris-borate), Ix 
90mM Tris-borate 
2mM EDTA 
6x agarose gel loading buffer 
0.25% bromoplienol blue 
40% (w/v) sucrose in water 
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2.16.4 Reagents for SDS-PAGE 
2x SDS gel-loading buffer 
lOOmM Tris-Cl pH6.8 
200mM p-mercaptoetlianol 
4% SDS 
0.2% bromophenol blue 
20% glycerol 
P-mercaptoethanol was added just before the gel-loading buffer was 
used. 





0.144% (w/v) Coomassie Brilliant Blue R-250 
31.25% (v/v)ethanol 
10% (v/v) acetic acid 
Destaining solution 
25% (v/v) ethanol 
8% (v/v) acetic acid 
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2.16.5 Reagents for Western blot 
Transfer buffer 




20% (v/v) methanol 
TBST 
lOmM Tris-Cl pH8.0 
ISOmMNaCl 
0.05% Tween 20 
TBSTB 
TBST containing 0.3% Bovine Serum Albumin 
AP buffer 
lOOmM Tris-Cl pH 9.5 
lOOmM NaCl 
5 m M MgCU 
BCIP 
5-Brotrio-4-chloro-3"-indolylphosphate 




(50mg/ml in 70% dimethylformamide) 
2.16.6 Reagents for DNA sequencing 
40% acrylamide 
38g Acrylamide 
2g N ' ,N ‘ -methylene-bisacrylamide 
The mixture was dissolved in water. The solution was made up to 
100ml after the solute had dissolved. 5g of amberlite ion exchange 
resin (Sigma) was added and the mixture was stirred at room 
temperature for 30 min for the adsorption of metal ions that might 
inhibit the polymerization of acrylamide. The resin was then removed 
by filtration through a 3 M M filter paper. The acrylamide solution was 
stored at 4。C in a blue cap bottle. 
2.16.7 Reagents for electroblotting using PVDF 
lOx CAPS buffer 
lOx stock (lOOmM, pHll) solution was prepared by dissolving 22.13g 
of 3-[cyclohexlamino]-l-propane-sulphonic acid in 990ml of de-
ionized water. The solution was then titrated with 2 M N a O H to pHll 
and de-ionized water was added to make a final volume of 1 litre. The 
solution was stored at room temperature. 
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Chapter Three 
The Study of Antigenic Determinants of TCS by Transposon 
Mediated Deletion Mutagenesis 
3.1 Introduction 
In order to study the antigenic determinants of TCS, deletion 
mutants were produced by transposon mediated mutagenesis. The 
approach to construct deletion library using bacterial InlOOO transposon is 
outlined diagramatically in Fig. 3.1. 
TnlOOO is a natural part of the E, coli F sex factor and transposes 
into other plasmids co-habiting the same male bacterium at low frequency. 
During transposition, InlOOO is duplicated in a transitory linkage of F 
factor joined with the target plasmid. Once in the female or recipient, this 
co-integrate molecule undergoes a site-specific recombination reaction to 
restore F factor and release a target plasmid with a transposon itisertion 
t 
(Sedgwick etal, 1991). 
After transposition，TnWOO would be inserted randomly into the 
plasmid containing the TCS gene sequence. If the TnlOOO was inserted 
within the TCS coding sequence, premature translation termination would 
occur. This is because both the gamma and delta ends of the TnlOOO 
possess the translation teniiination codons in three reading frame (Fig.3.2). 
The codons marked with * are the corresponding stop codons for 
premature translation termination. The insertion of transposon into the 
TCS coding sequence would therefore result in the production of a series 
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Transposition Recombination 
Fig 3 1 Transposition mechanism for InWOO mutagenesis of plasmid D N A . TnlOOO on 
sex factor F transposes into the target plasmid pET58210 which contains the TCS gene 
sequence. The transposition results in the formation of a co-integrate. The co-mtergrate 
is transferred to a female cell where site-specific recombination in Tn / 000 will result 
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of TCS truncated protein with different length. The precise location of the 
TnlOOO insertions were found out by D N A sequencing. The truncated 
TCS protein was then analysed by Western Blotting. Shorter truncated 
TCS protein would be recognized by fewer antibodies. Together with the 
precise location of the TtilOOO insertion sites, a detail mapping of the 
epitopes of TCS can be generated. 
3.2 Results 
3.2.1 Construction of deletion library of pET58210 by transposon 
niediated mutagenesis 
i 
To perform transposon TnlOOO mediated mutagenesis, the first step 
is to transform the donor strain, MH1345, with the target plasmid, 
pET58210 which contains the TCS gene sequence. MH1345 has a recAl 
mutation to improve plasmid stability. The rpsV and deoC markers of 
MHI345 confer streptomycin sensitivity and thymine dependency 
respectively and were used to counter-select against the donor after 
mating. MH755 was used as recipient cells which has a rpsL mutation and 
hence confers resistance to streptomycin. After bacterial mating the 
recipient cells were selected by streptomycin and ampicillin. The presence 
of streptomycin and lack of thymine prevents the growth of donors after 
mating. Since the only means of target plasmid transfer is via a 
transposition event, all surviving recipients on the selective plates Contain 
transposed target plasmids. The plate which had spreaded with 10-100|il 
of mating samples were found to contain about 10-1000 single colonies on 
the selective plates. As shown in Fig.3.3, the size of the plasmids isolated 
from the recipient cells were larger than pET58210 which showed that a 
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Fig. 3.3. Lanes (1,2): plasmid D N A isolated after the 
mating. Lane (3): pET58210. Lane (4): X Hind III marker. 
I 
Fig. 3.4. Laiie (1):, plasmid D N A isolated after mating 
was cut with Kpn I, Lane (2): A, HinA III marker. 
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TnlOOO had inserted into the pET58210 through the transposition process. 
Because the pET58210 is 5.4kb and the TnlOOO is 5.9kb, the mutated 
plasmid should be 11.3kb. In Fig.3.4, the mutated plasmid was cut with 
Kpnl which has only one cutting site in TnlOOO and a fragment of about 
11.3kb was observed. This shows that the plasmid D N A isolated from the 
recipient cell was the result of TnWOO inserted into pET58210. About 300 
independent recipient colonies were isolated and they were then undergone 
PCR insertion mapping to find out whether the TnlOOO was inserted within 
- i -
the TCS gene sequence. 
3.2.2 PCR insertion mapping of the transposon inserted clones 
Because the TCS gene sequence is 0.747kb and the pET58210 was 
5.4kb ill size, theoretically only about 10% (0.747/5.4) of the imitated 
plasmid will possess a TnlOOO inserted within the TCS gene sequence. 
Therefore PCR insertion mapping was done to screen for these 10% 
mutants. The methods of PCR insertion mapping was described in section 
2.5. The strategy of the PCR insertion mapping was shown in Fig.3.5. If 
TnlOOO was inserted within the TCS gene sequence, the first reaction will 
result in the production of the N-terminal TCS gene fragment and the 
second reaction will result in the production of the C-terminal TCS gene 
fragment. The sum of the length of the two fragments will equal 
approximately to that of the whole TCS gene fragment. The use of both 
TnlOOO gamma and delta end primers in the same reaction is because 
TnlOOO can insert in either orientation. Fig.3.6 is a typical result of the 
PCR insertion mapping. Lanes 3&4 and lanes 1&2 have no reaction 
product which meaiis that TnlOOO was inserted outside the TCS gene 
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Fig. 3.6. Typical results of PCR insertion mapping. Lanes 
1, 3, 5 and 11 are the first PCR products of 4 different 
mutants. Lanes 2，4, 6 and 12 are the second PCR 
products of 4 different mutants. Lanes (1&2, 3&4, 
11&12): TnlOOO inserted outside TCS gene sequence. 
Lane (5&6): TnlOOO inserted within TCS gene sequence. 
Lane (8): 123 base pairs ladder marker. Lane (9): X Hind 
III marker. 
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means that TnJOOO was inserted near the C-terminal of the TCS gene 
sequence as confirmed by D N A sequencing. In lanes 5&6, two reaction 
products were observed which shows that the TnWOO was inserted within 
the TCS gene sequence. Three hundred clones from section 3.2.1 were 
screened by PGR insertion mapping and 15 clones showed positive result 
in PGR insertion mapping reaction. These mutants were than verified by 
D N A sequencing to locate the exact position of the transposon insertion 
site. 
3.2.3 DNA sequencing of positive clones after the PCR insertion 
mapping. 
The precise site of transposon insertion was determined by D N A 
sequencing with primers complementary to unique sequence in the gamma 
end of TnWOO. The tnWOO insertion can be recognized because the 
gamma end of TnlOOO is characterized by a sequence of inverted repeats. 
A typical sequencing gel with four clones is shown in Fig.3.7, The 
polymerase initially copies the transposon sequence up to A A A C C C C 
which is the terminal inverted repeats of TnlOOO and subsequently the 
TCS gene sequence at the transposon insertion position. For clone 86, the 
TCS sequence is TTGTAGTAAAAC.…For clone 163, the TCS sequence 
is TTATTTTGCCTG.…For clone 243, the TCS sequence is 
TTTGAAGCCTTT…and for clone 277, the TCS sequence is 
GAATATGAAGCG,…The 15 clones that were isolated by PCR insertion 
mapping were all sequenced and the D N A were analysed by a computer 
programme. 
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86 163 243 277 
A T G C A T G C A T G C A T G C 
• 
Fig. 3.7. Sequencing results of mutants 86, 163, 243 and 
277. The polymerase initially copies the TnlOOO sequence 
up to A A A C C C C and subsequently the TCS cDNA 




3.2.4 Computer analysis of the DNA sequence 
Sequences of the positive clones were analysed by the computer 
programme DNASIS (Hitachi). The analysis aims at comparing the 
sequence of the positive clone with the TCS gene sequence and hence 
found out the exact location of the TnWOO insertion site and its insertion 
orientation. Since the TnlOOO can insert in either orientation, thetefore the 
determination of the orientation of the TnlOOO is very important for two 
reasons. 
Firstly, the insertion of the TnlOOO at the TCS sequence will result 
in the duplication of five bases at the target D N A , and when one reads the 
sequencing ladder, correction of the insertion should be made before 
finding the TnlOOO insertion site . 
Secondly, the orientation of the TnlOOO insertion will determine 
which subcloning procedures should be followed (section 3.26). After 
computer analysis, the exact location of the TnlOOO insertion site and the 
orientation of the inserted Tn/腳 will be known. The insertion position of 
the TnlOOO of the 15 clones is shown in Fig. 3.8. 
3.2.5 Expression of mutated plasmids with TnlOOO 
Mutated plasmid with TnlOOO inserted within the TCS gene 
sequence was expressed in the T7 R N A polymerase driven expression 
system to produce the imitated protein. Fig. 3.9 shows the expression 
products. Unexpectedly, expression of the mutated TCS with TnlOOO 





























































































































































































































































































































































































Fig. 3.9. The expressed products analysed by SDS-PAGE 
and Western blotting. Lanes (1,2): mutants with T^n/000 
29, 38 respectively. Lane (3): normal expressed TCS. 
Lane (4): purified TCS. Lane (5): molecular weight 





were subcloned to eliminate the effect of TnlOOO on the expression of 
truncated TCS protein. 
3.2.6 Subcloning of the positive clones that have been characterized 
by DNA sequeiicing 
As we suspect that TnlOOO may have an adverse effect on the 
expression of trimcated TCS, subcloning procedures were followed to 
isolate the mutated TCS gene fragment. Because the TnlOOO can insert in 
either orientation，two subcloning methods were followed depending on 
the TnlOOO inserted orientation in the mutated clones. 
The methodology of the first subcloning method is outlined in 
section 2.8.1 and the strategy of subcloning is shown in Fig J. 10. If the 
delta end of the transposon is orientated in the N-terminal of TCS gene 
sequence, the deleted TCS gene sequence can be isolated directly by 
cutting with Nco I and BamH L 
The methodology of the second subcloning method is outlined in 
section 2.8.2 and the strategy of subcloning is shown in Fig. 3.11. A 
InlOOO gamma end mutagenic primer with the addition of a BamH I site 
was made (sequence shown at section 2.7.2). Together with the pET 
forward primer, the deleted TCS gene fragment was amplified by PCR. 
Among the 15 TnlOOO inserted plastnids, eight of them were 
subcloned by the first method and seven of them were subcloned by the 
second method. 
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Fig. 3.10 Subcloning of the deleted TCS gene fragment at the 
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Fig.3.11 Subcloiiing of the deleted TCS gene fragment at the Tn lOOOg^ mm^  end byPCR. 
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3.2.7 Overexpression of mutated TCS protein with the T7 RNA 
polymerase driven expression system 
After the subdoning procedures, mutated proteins were produced in 
the T7 R N A polymerase driven expression system (section 2.10). Thirteen 
mutated proteins were expressed successfiilly in this system. Fig.3.12 
shows the result of the thirteen expressed protein analysed in a 15% SDS-
PAGE. Expressed proteins are shown as swollen protein bands and the 
molecular weight of the protein ranged from 6,000 to 27,000. The mutated 
proteins observed were actually fusion proteins which contained 2 to 36 
transposon-encoded amino acids at its C-lenniniis. The numbers of amino 
acids added are shown in the following table: 
T n / _ end frameshift' additional amino acids 
delta end 0 2 
1 36 
2 12 
gamma end 0 2 
1 17 
2 36 
'number of bases between last complete codon of target sequence and start of 
T n / 嫩 
The mutated proteins were then analysed by Western blotting. 
3.2.8 Analysis of TCS deletion mutants by Western blotting 
The mutated proteins were analysed by Western blotting for the 
presence of antigenic epitopes. The total cell proteins were first applied to 
a 15% SDS-PAGE (sections 2.2.12 and 2.11). After electrophoresis, the 
proteins were transferred to a N C membrane for the binding of anti-TCS 
antibody (section 2.2.14) 
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I m U H H ^ ^ B J 
Fig. 3.12. SDS-PAGE showing the successfully expressed 
TCS deletion mutants. Lane (1): purified TCS, lane (2): 
natural TCS, lane (3): mutant 38, lane (4): mutant 308, 
lane (5): mutant 86, lane (6): mutant 101, lane (7): mut^t 
4 lane (8): mutant 201, lane (9): mutant 163，lane (10): 
mutant 243, lane (11): mutant 277, lane (12): m u t a n t 29 
lane (13): mutant 21, lane (14): mutant 35 and lane (15): 








Anti-TCS polyclonal antibody analysis 
Fig.3.13 shows the result of Western blotting using anti-TCS 
polyclonal antibody. All the thirteen mutants can react with the polyclonal 
antibodies as shown. The smallest deletion protein is clone 35 which 
contains only 21 amino acids of the N-teraiinal of TCS. Among the 
mutants, mutants 29, 21 and 35 gave a weaker signal in Western blotting 
than other mutated protein. 
Classical anti-TCS monoclonal antibody analysis 
Fig.3.14 shows the result of Western blotting if the mutated proteins 
interacted with a classical anti-TCS monoclonal antibody generated by 
hybridoma technique. All the thirteen mutants can react with the 
monoclonal antibody. Degradation products of the mutated proteins were 
not observed in the Western blot. The smallest mutated protein (no. 35) 
could also react with the monoclonal antibody. Mutants 29 and 21 gave 
the weakest signal compared to the other mutated proteins. 
Recombinant anti-TCS Fab fragment 
Fab fragment was prepared as shown in section 2.2. Forty two 
clones of the Fab fragment were produced by this method. All these Fab 
fragments were expressed as described in section 2.3 and interacted with 
the deletion mutated TCS protein. These procedures should screen out the 
different fragments that recognize different epitopes on the TCS protein. 
J 
To our surprise, we found that all the forty four clones of Fab fragments 
/ • 
produced the same interacting pattern in Western blotting with the 
truncated proteins. Fig.3.15 shows a typical result of Western blotting 
f 
/ . . , 
——-
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Fig. 3.13. SDS-PAGE and Western blotting analysis of 
TCS deletion mutants by anti-TCS polyclonal antibody. 
Lane (1): natural TCS，lane (2): mutant 38，lane (3): ； 
mutant 308, lane (4): mutant 86, lane (5): mutant 101, lane 
(6): mutant 4，lane (7): mutant 201, lane (8): mutant 163, 
lane (9): mutant 243, lane (10): mutant 277, lane (11): 
mutant 29, lane (12): mutant 21, lane (13): mutant 35 and 
lane (14): the molecular weight marker. 
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Fig. 3.14. SDS-PAGE and Western blotting analysis of 
TCS deletion mutants by anti-TCS classical monoclonal | 
antibody. Lane (1): natural TCS，lane (2): mutant 38, lane ！ 
(3): mutant 308, lane (4): mutant 86, lane (5): mutant 101, | 
lane (6): mutant 4，lane (7): mutant 201, lane (8): mutant ！ 
163, lane (9): mutant 243，lane (10): mutant 277, lane 
(11)： mutant 29, lane (12): mutant 21，lane (14): mutant 
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Fig. 3.15. Western blotting analysis of TCS deletion 
mutants by Fab fragment. Lane (1): natural TCS, lane (2): 
mutant 38, lane (3): mutant 308，lane (4): mutant 86，lane 
(5): mutant 101, lane (6): mutant 4, lane (7): mutant 201, 
lane (8): mutant 163’ lane (9): mutant 243, lane (10): 
mutant 277, lane (11): mutant 29, lane (12): mutant 21 and 
lane (13): mutant 35. 









using anti-TCS Fab fragment. The result was also similar to that of 
classical monoclonal antibody. As in the previous case, the smallest 
mutated protein (no.35) could also react with the Fab fragment and 
mutants 29 and 21 interacted much weaker with the Fab fragment. 
3.2.9 Construction of deletion mutants that exclude the 21 amino 
acids in the N-terminal of TCS 
In view of mutant 35 which contains the first 21 amino acid residues 
of TCS can still interact with polyclonal, monoclonal and Fab fragment, 
mutants with the deletion of the first 21 amino acid residues were 
constructed. The methodology was shown in section 2.9 and the strategies 
of the construction are shown in Fig.3.16. The results of expression and 
Western blotting are shown in Fig.3.17. With the exclusion of the first 21 
amino acids, the mutants can still bind with the polyclonal, monoclonal 
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Fig.3.16 Subdoning of the deletion mutants without the 21 amino acids 
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Fig. 3.17. SDS-PAGE and Western blotting of mutant 4 
and 308 which have their N-terminal 21 amino acids 
deleted. They were analysed by polyclonal antibody， 
monoclonal antibody and Fab fragment. Lanes (2): and 
(3): are mutants 4 and 308 respectively. Lanes (4): and 
(5): are mutants 4 and 308 with deletion of the 21 amino 
acids respectively. Lane (1): is natural TCS. 
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3.3 Discussion 
In recent years transposable elements have been increasingly 
exploited as tools for mutational analysis and in vivo genetic engineering 
in a diverse array of microorganisms. Among their major uses are insertion 
mutagenesis markers; analysis of transcriptional and translational 
regulation and protein localization; the introduction of engineered genes 
into organisms; and D N A sequencing (Berg et al. 1989). In this study, 
transposon mutagenesis was used to construct deletion mutants of TCS 
protein. The mutants were then reacted with antibodies to define epitopes 
on TCS protein. Similar work has been done by Sedgwick et al. (1991) to 
map for the epitopes of muscular dystrophy protein. TnlOOO was used for 
insertion mutagenesis is because insertion mutagenesis can be performed 
in very simple procedures with little in vitro manipulation. In this study, 
deletion mutants of TCS gene sequence can be produced by simple 
transformation and bacterial mating. 
One problem involved in the use of TnlOOO as mutagenic agents is 
that extensive screening procedures are required for the finding of the right 
mutated clones (Strathmaim et al., 1991). As stated in the result section 
(3.2.2), theoretically only 10% of the mutated clones possesses a TnlOOO 
inserted within the TCS gene sequence. Therefore a rapid and simple 
procedure was required to screen for a large number of mutated clones to 
identify the target mutants. In this study PGR insertion mapping was used. 
Other methods of screening are also available. For example the use of 
restriction enzyme mapping for the mutated plasmid. However problems 
have raised in finding the suitable restriction site and in the preparation of 
/ 
a large amount of plasmid D N A (Strathmaim et al., 1991). On the 
一. 
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contrary, PGR reaction requires small amount of substrate and can screen 
for a large amount of mutants in a short period. After PGR insertion 
mapping, it was shown that only 5% of the mutants contain the TnlOOO 
inserted within the TCS gene sequence compared to 10% of the theoretical 
value. This may be due to the fact that TnlOOO has an insertion preference 
for the high A T content in local sequence (Sherratt, 1989)，therefore 
variation in insertion frequency may presence in different regions of the 
sequence. 
Another problem encountered in this project is the expression of the 
protein in T7 R N A polymerase driven expression system. After the 
screening and sequencing of the usefiil mutants (TnlOOO inserted within 
TCS gene sequence), the mutants were expressed in the T7 R N A 
polymerase driven expression system. However, the expressed product 
was the wild-type TCS protein as shown by Western blotting (Fig. 3.9) 
and protein finger-printing (result not shown). W e are not sure of the exact 
reason. Contamination of the mutants with the pET58210 plasmid was not 
possible because in agarose gel electrophoresis, only single D N A bands 
were observed for the mutants with different molecular sizes compared to 
pET58210. Contamination of mutated plasmid with TnlOOO inserted 
outside TCS gene sequence was also not possible because in sequencing 
reaction, only one exact sequence was observed and single colony was 
picked for expression of mutants. Therefore the remaining explanation is 
that TnlOOO is not stable in the expression host (BL21 DE3 pLysS) for 
some reasons and hence leads to the recombination of the mutants and 
restores the nortnd pET58210 plasmid. However in vivo excision of 
TnlOOO is rare as TnWOO is quite a stable transposon (Sherratt, 1989). 
/ • 
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Also, if this is the case, owing to the duplication of the insertion site, it is 
highly impossible that the TCS D N A is still in frame and leads to the 
expression of full length protein. Nevertheless, owning to limitation of 
time, this phenomenon was not further investigated. 
Because of the possible interference of TnlOOO on the expression of 
the deletion mutants, subcloning procedures were followed to eliminate 
TnlOOO in the expression system. Two subcloning procedures were 
employed to adopt for different insertion orientation of TnlOOO in the TCS 
gene sequence. The strategies of both subcloning procedures are outlined 
in 3.2.6. In both approaches, the translation stop codons of the TnlOOO in 
delta end or gamma end were included. This aims at to provide a 
translation stop codon for the expression of deletion mutants. After 
subcloning, the deletion mutants can be expressed in a substantial amount 
for easy recognition. This seems to imply that TnlOOO was unstable in the 
expression host and led to unsuccessful expression of deletion mutants. 
After the successful expression of 13 out of 15 deletion mutants, the 
mutated proteins were analysed by Western blotting with the use of anti-
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The results of Western blotting of some mutants may give 
information on the antigenic sites of TCS protein and they are summarized 
in the following table: 
Corresponding Result of Result of Result of 
amino acid of Western Western Western 
TCS blotting with blotting with blotting with 
polyclonal monoclonal Fab fragment 
antibody antibody 
TCS 1-247 + + + + + + + + 
mutant 277 M ^ + + + + + + + + 
mutant 21-142 + + + + + + + + 
mutant 29 + + 
mutant 21 "“ ^ + + 
mutant 35 T^I + + + + 
+: relative reactivities between the protein and antibody. 
Polyclonal antibody 
From the result of polyclonal antibody analysis, all the mutants can 
bind with polyclonal antibody. However the three shortest deletion 
mutants; mutant 29, 21 and 35 showed a weaker signal in the binding 
towards polyclonal antibody. One possible explanation is that two groups 
of antibodies are presence in the polyclonal antibody. One type of 
antibody recognized the amino acid sequence between residues 96-108, 
therefore after the deletion of this region (mutants 29, 21 and 35) a weaker 
signal was observed in Western blotting. Another explanation is that a 




1 mutant 4 that has its 11 amino acids at the N-terminal deleted. ， 
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of epitopes between 1-108, if residues 96-108 were deleted, there was a 
reduction in epitope numbers and hence a reduced signal. The third 
possibility is that deletion of the residues 96-108 perturbed the 
conformation of epitopes recognized by the concerned antibody. 
The shortest deletion mutant; mutant 35, can still bind with the 
polyclonal antibody. This means that this region (residues 1-21) 
corresponds to one of the antigenic sites recognized by polyclonal 
antibody. However the deletion of amino acid residues 1-21 in mutant 4 
did not result in the total elimination or decrease in binding by polyclonal 
antibody. This means that the residues 1-21 are only a part of the antigenic 
site recognized by the polyclonal antibody. 
Monoclonal antibody and Fab fragment 
The result of Western blotting of the deletion mutants using 
monoclonal antibody and the forty four clones of Fab fragment were the 
same. This means that both the monoclonal antibody and the forty four 
clones of Fab fragment recognized the same antigenic site on the TCS 
protein. The shortest deletion mutant; mutant 35, can still bind with the 
monoclonal antibody and Fab fragment. This means that this region 
(residues 1-21) corresponding to one of the antigenic sites recognized by 
the monoclonal antibody and the Fab fragments. The deletion of amino 
acid residues 1-21 in mutant 4 did not result in the total elimination of 
binding by the monoclonal antibody and Fab fragment. This means that the 
residues 1-21 are only a part of the antigenic site recognized by the 
monoclonal antibody and Fab fragment. ； 
i ^ 
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The identical antigenic site recognized by the forty four clones of 
Fab fragment can be explained as follow. During the process of anti-TCS 
Fab fragments production (section 2.3), the mouse was boosted by TCS 
protein for four times before sacrificed for the spleen and there might be 
bias in the recognition of a particular epitope by the immune system. Also, 
in the process of the construction of recombinant Fab fragment, there were 
a series of procedures to amplify the antibody gene by PGR. This process 
might result in the loss of a variety of different type of Fab fragments that 
recognized different antigenic determinants and hence resulted in the 
isolation of a single clone of Fab fragments. 
From the result of Western blotting a weaker signal was observed in 
mutants 29 and 21 which correspond to the amino acid residues 1-96 and 
1-93. From Fig.3.18 it can be shown that the region of the amino acid 
residues of 96-107 are in a central region of a well-ordered anti-parallel p-
/ 
sheet structure. Therefore destruction of this region may result in affecting 
the binding affinity towards the monoclonal antibody and the Fab 
fragments. After the total deletion of the region of the anti-parallel P-sheet 
structure as shown in mutant 35 (residues 1-21) in Fig.3.19, the Western 
blotting signal became normal again. 
Based on the above discussion on the result of Western blotting by 
monoclonal antibody and Fab fragment, it can be concluded that in early 
discussion the weakening of Western blotting result in mutants 29, 21 and 
35 with the use of polyclonal antibody is due to the perturbation of the 
conformation of epitopes recognized by the concerned antibody. Therefore 
from the result of transposon mediated deletion mutagenesis epitopes 
85 
mapping, it can be concluded that a discontinuous epitope is presence on 









Fig. 3.18. Computer generated 3D-structure of TCS. 













Fig. 3.19. Computer generated 3D-structure of TCS. 












The Study of Antigenic Determinants on TCS by Chemical and 
Enzymatic Cleavages of TCS Protein. 
4.1 Introduction 
The second approach for studying the antigenic determinants of 
TCS protein is to produce different fragments by means of chemical or 
enzymatic method and then analyse by Western blotting by different 
antibodies. 
The enzymatic method includes the use of alkaline protease, 
endoprotease Lys-C and endoprotease Glu-C. They are the enzymes 
commonly used in the cleavage of protein to produce fragments for further 
structure or sequence analysis. Alkaline protease cleaves at random site of 
the protein in alkaline condition. Endoprotease Lys-C cuts specifically at 
lysine peptide bonds under alkaline condition. Endoprotease Glu-C from 
Staphylococcal protease strain (V8) cleaves specifically at glutamyl 
peptide bonds and sometimes at aspartyl peptide bonds. These enzymes 
are active in alkaline condition with the presence of 1% SDS. 
—, 
For chemical cleavage, cyanogen bromide was used. Cyanogen 
bromide has been commonly used to produce protein fragments for protein 
sequencing. It specifically cleaves at methionine residues in the protein 
sequence. Because the occurrence of methionine residue in protein is low, 
large protein jfragments can be generated. The mechanism of cyanogen 
bromide cleavageit methionine is shown in Fig. 4.1. Methionine residues 
are converted into a mixture of C-terminal homoserine residues and 
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Fig.4.1: Mechanism of the reaction of cyanogen 






4.2.1 Preparation of recombinant TCS protein 
In order to provide the substrate for fragment production in the 
analysis of antigenic site on TCS, pure recombinant TCS protein was 
produced in large quantity. Recombinant TCS protein was expressed in a 
T7 R N A polymerase driven expression system (Zhu et a/., 1992). 
•V 
Cell lysate from 1 litre induced bacterial culture was loaded to a 
CM-sepharose column according to section 2.12. A gradient of 0-0.5M 
NaCl was applied and the elution profile of TCS is shown in Fig.4.2. Then 
TCS was further purified through a second CM-sepharose column with a 
gradient of0-0.5MNaCl and the elution profile is shown in Fig.4.3. After 
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4.2.2 Proteolytic and chemical cleavages of recombinant TCS 
After digestion of TCS protein with alkaline protease，endoprotease 
Lys-C and endoprotease Glu-C (section 2.13), the digestion mixtures were 
then analysed by 16.5% high resolution Tricine SDS-PAGE (section 2.14). 
After TCS protein has reacted with cyanogen bromide, the reaction 
product was dried by lyophilization. The dried powder was then analysed 
by 16.5% high resolution Tricine SDS-PAGE. 
Fig.4.4 shows the result of 16.5% high resolution Tricine SDS-
P A G E analysis of the proteolytic and chemical cleavage product of TCS 
protein. The digestion of TCS with alkaline protease generated two 
distinct small peptide fragments. The digestion of TCS with endoprotease 
Lys-C generated a large number of protein fragments with different 
molecular sizes. The digestion of TCS with endoprotease Glu-C generated 
fewer protein fragments when compared to endoprotease Lys-C digestion. 
The cleavage of TCS with cyanogen bromide generated four distinct 
protein fragments. 
Because the banding pattern of the low-range molecular markers did 
not correspond to their molecular weights as given by the supplier, we 
could not accurately determine the molecular sizes of the fragments 
generated by proteolytic and chemical cleavage. Nevertheless, the 
cyanogen bromide products were sent to Dr. R. Aplin for mass 
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Fig. 4.4. The TCS cleaved products analysed by high resolution 
16.5% Tricine SDS-PAGE. Lane (1) alkaline protease digested 
product, lane (2) endoprotease Lys-C digested product, lane (3) 
endoprotease Glu-C digested product, lane (4) cyanogen 
bromide cleavage product, lane (5) low-range molecular weight 
marker (Promega), lane (6) mid-range molecular weight marker 
(Phannacia), lane (7) purifed TCS. CI, C2, C3 and C4 are the 
protein fragments that had been analysed by N-termmal 
determination and mass spectrometry. Gl, G2, G3 and G4 are 










4.2.3 Western blotting analysis of TCS protein fragment generated 
by proteolytic and chemical cleavage 
After electrophoresis using high resolution 16.5% polyacrylamide 
gel. Western blotting was performed to analyse the antigenic characteristic 
of these fragments. Anti-TCS polyclonal antibody, monoclonal antibody 
and recombinant Fab fragment were used. 
Polyclonal antibody 
With reference to Fig.4.4, most of the fragments generated by 
various proteases and cyanogen bromide could bind with the polyclonal 
antibodies (Fig.4.5). Only the smallest fragment of the Glu-C digested and 
cyanogen bromide cleavage products did not react with anti-TCS 
polyclonal antibody. 
Classical monoclonal antibody 
Fig.4.6 shows the result of Western blotting with the use of anti-
TCS classical monoclonal antibody. Fewer bands were observed as 
compared to Western blotting using polyclonal antibody. The digestion 
product of alkaline protease did not react with monoclonal antibody. Glu-
C digested product and cyanogen bromide cleavage product revealed 
distinct bands while there were many partially digested fragments for Lys-
C. 
Recombinant Fab f r a ^ e n t 
Fig.4.7 shows the result of Western blotting with the use of Fab 
/ 
/ 
fragment. Results were similar to the classical monoclonal antibody. 
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Fig 45 The TCS cleaved products analysed by W e s t ^ 
Sotting with anti-TCS polyclonal antibody. Lane (1) alkalme 
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Fig. 4.6. The TCS cleaved products analysed by Western 
blotting with anti-TCS classical monoclonal antibody. Lane (1) 
purifed TCS, lane (2) mid-range molecular weight marker 
(Pharmacia), lane (3) low-range molecular weight marker 丨 
(Promega), lane (4) cyanogen bromide cleavage product, lane | 
(5) endoprotease Glu-C digested product, lane (6) endoprotease ； 
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Fig. 4.7. The TCS cleaved products analysed by Western 
blotting with anti-TCS recombinant Fab fragment. Lane (1) 
purifed TCS，lane (2) mid-range molecular weight marker 
(Pharmacia), lane (3) low-range molecular weight marker 
_ (Promega), lane (4) cyanogen bromide cleavage product, lane 
(5) endoprotease Glu-C digested product, lane (6) endoprotease 
Lys-C digested product, lane (7) alkaline protease digested 
product. 






Nevertheless，Fab fragment gave a much weaker signal comparing to 
monoclonal antibody. 
4.2.4 N-terminal Determination of the antigenic TCS protein 
fragment produced by chemical cleavage 
Because the cyanogen bromide cleavage of TCS resulted in the 
production of distinct protein fragments, these fragments were toher 
analysed by N-terminal determination. 
Protein fragments of TCS produced by cleavage were separated by 
SDS-PAGE, then blotted to a PVDF membrane (section 2.13) and sent for 
N-terminal determination. 
Apart from N-terminal determination of the cyanogen bromide 
cleaved TCS protein fragments, the molecular weight of the cleavage 
product was determined by mass spectrometry by Dr. Robin Aplin at the 
University of Oxford. The results of N-terminal determination and the 
mass spectrometry are shown in the followmg table 4.1. Because of 
cyanogen bromide cleaves specifically at the methionine residue and there 
are only five methionine residues in the TCS protein, the length of the 
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eight of the cyanogen brom
ide cleaved product 
4.3 Discussion 
Proteolytic and chemical cleavage of protein into smaller fragments 
have been commonly used in protein sequencing. In this study these 
approaches were used to produce TCS protein fragments for subsequent 
antigenic analysis. 
In the study of the protein fragments, a 16.5% high resolution 
Tricine SDS-PAGE (section 2.12) was used. In the preliminary study, 
other gel systems were used for the separation of small molecular weight 
fragments produced by proteolytic or chemical cleavage. They included 
15% and 20% SDS-PAGE (section 2.1.12), precasted 18% SDS-PAGE 
and 4-20% gradient gel (NOVEX). However only the 16.5% high 
resolution Tricine SDS-PAGE gave a satisfactory result on the separation 
of the protein fragments. One disadvantage of this gel system is the long 
preparation time in gel setting and the gel needed to run slowly to produce 
the required resolution and to prevent overheating. 
Fig.4.4 shows that both proteolytic and chemical approaches can 
produce different TCS fragments. The digestion products of TCS by 
alkaline protease and endoprotease Lys-C were not suitable for further 
analysis. This is because the digestion of TCS by alkaline protease was too 
complete and no distinct fragment was observed. On the contrary the 
digestion of TCS by endoprotease Lys-C gave too many partially digested 
fragments. On the other hand both the Glu-C and the cyanogen bromide 
digestion gave distinct'protein fragments for further analysis. Proposed 
sizes of Glu-C fra^ents Gl, G2, G3, and G4 and their interactions with 
various antibodies are listed in Table 4.2. Owning to the limitation of time,. 
the location of these Glu-C products had not been mapped for this thesis. # 
103 
Fragments generated by cyanogen bromide cleavage could be 
resolved in 16.5% TricineSDS-PAGE (Fig.4.4). Therefore further study 
was done on these fragments to investigate their molecular sizes and N-
teraiinal sequences. The cyanogen bromide cleaved fragments were 
marked as CI, C2, C3 and C4 (Fig.4.4). These fragments were then sent 
for N-terminal determination and mass analysis. The fragments were then 
mapped on the TCS amino acid sequence (Fig.4.8 ) 
CI actually contains two fragments: 1 and 2. Fragment 1 
corresponds to amino acids M O O of TCS. It is actually the incomplete 
digestion product which contain C2 fragment B and C4. Fragment 2 of CI 
corresponds to amino acids 154-247 of the TCS protein. All these two 
fragments of CI could bind with all three types of antibody (Fig.4.5, 4.6 & 
4.7). 
C2 actually contains two fragments: A and B. They could be 
separated for N-terminal determination because two distinct bands were 
observed in C2 after the PVDF membrane was stained. Fragment A of C2 
coiresponds to residues 91-153 of TCS protein and it is actually the 
incomplete digestion product which contain C3 and C4. By comparing the 
result of Western blotting of C2 fragment A with polyclonal antibody 
(Fig.4.5), monoclonal antibody (Fig.4.6) and Fab fragment (Fig.4.7), it was 
shown that this fragment could only recognize by polyclonal antibody. 
Fragment B ofC2 corresponds to the residues 1-72 of TCS protein. This 









*** SEQUENCE LIST *** (N = = = > C) 
10 
N- Met Asp Val Ser Phe Arg Leu Ser Gly Ala Thr Ser Ser Ser Tyr Gly Val Phe 
20 30 
lie Ser Asn Leu Arg Lys Ala Leu Pro Asn Glu Arg Lys Leu Tyr Asp lie Pro 
40 ‘ 50 
Leu Leu Arg Ser Ser Leu Pro Gly Ser Gin Arg Tyr Ala Leu lie His Leu Thr 
60 70 
Asn Tyr Ala Asp Glu Thr lie Ser Val Ala lie Asp Val Thr Asn Val Tyr lie 
80 90 
Met Glv Tvr Arg Ala Glv Asp Thr Thr Tyr Phe Phe Asn Glu Ala Ser Ala Thr 
100 
Glu Ala Ala Lvs Tvr Val Phe Lvs Asp Ala Met Ar^ Lys Val Thr Leu Pro Tyr 
no 120 
Ser Gly Asn Tyr Glu Arg Leu Gin Thr Ala Ala Glv Lys lie Arg Glu Asn He 
130 
Pro Leu Gly Leu Pro Ala Leu Asp Ser Ala lie Thr Thr Leu Phe Tyr Tyr Asn 
150 160 
Ala Asn Ser Ala Ala Ser Ala Leu Met Val Leu He Gin Ser Thr Ser Glu Ala 
170 180 
Ala Arg Tyr Lys Phe lie Glu Gin Gin De Gly Lys Arg Val Asp Lys Thr Phe 
190 
Leu Pro Ser Leu Ala He De Ser Leu Glu Asn Ser Trp Ser Ala Leu Ser Lys 
200 210 
Gin He Gin De Ala Ser Thr Asn Asn Gly Gin Phe Glu Ser Pro Val Val Leu 
220 230 
He Asn Ala Gin Asn Gin Arg Val Thr He Thr Asn Val Asp Ala Gly Val Val 
240 
Thr Ser Asn He Ala Leu Leu Leu Asn Arg Asn Asn Met Ala *** -C 
Fig. 4.8. TCS amino acid sequence showing the cyanogen bromide cleaved 
fragments. Normal text, C2 fragment B. Underlined text, C4. Italic text, C3. 







C3 corresponds to residues 102-153 of TCS protein and it only 
interacted with the polyclonal antibody. 
C4 corresponds to amino acids 74-100 of TCS protein and it did not 
interact with all the three types of antibody. 
From the results of Western blotting of these digestion products 
with monoclonal antibody and Fab fragment, it can be concluded that these 
antibodies are similar and recognize a discontinuous epitope. This epitope 
involves the sequence of the anterior part and posterior part of the TCS 
protein. The anterior part includes amino acid residues of 1-73 and the 
posterior part include residue of 154-247. Whereas the central region of 
TCS protein residue 74-153 (C3-C4) is not involved. 
On the other hand, an epitope was located by the polyclonal 
antibodies between residues 102-153 (Table 4.1). Also the interaction of 
C2 fragment A with polyclonal antibodies may be due to its epitope at 
102-153. 
Residues 74-100 seems to have no epitopes as all the three kinds of 










General Discussion and Future Study 
5.1 General Discussion 
In the study of the antigenic determinants of TCS protein, two 
approaches have been used, the first one is the construction of deletion 
mutants by transposon mediated mutagenesis developed by Sedgwick et 
al (1991). They successfully mapped the epitopes for the central helical 
region of muscular dystrophy. Another similar work using exonuclease III 
deletion instead of transposon mediated deletion mutagenesis was done by 
Gross and Rohemann (1990). They constructed the deletion mutants of 
baculovims capsid protein and then mapped for the epitopes within the 
protein. Deletion can be done by exonuclease III at both C-teraiinal and N-
terminal of the protein. A limitation of using transposon mutagenesis is that 
when an epitope covers different regions of a protein, such as in our case, 
all the deletion mutants will interact with the antibody. Hence only the 
antigenic site at the N-terminal of the protein can be unambiguously 
located. 
As shown in our study, because the epitope recognized by the 
monoclonal antibody is discontinuous (section 4.3). Only the first 21 
amino acids at the N-terminal region of TCS can be located as antigenic 
site. Hence we have to switch to another approach. 
/ 
J 
The analysis of the antigenic properties of proteolytic and chemical 
cleavage fragment'of protein has been used for some time for the analysis 
> 
of epitopes. Thisj^  approach is especially useful when the D N A sequence of • / 
the interested protein is not available. For example Morris (1989), had 
i 107 
f V � 
successfully identified an antigenic region of 53 amino acids at the C-
terminal of chicken creatine kinase with the use of cyanogen bromide and 
proteinase K. Man et al. (1991) used nitrothiocyanobenzoic acid and 
proteinase K also identified a 53 amino-acid antigenic fragment in human 
brain creatine kinase. One characteristic of this approach is that usually the 
identified antigenic fragment is very large and further isolation and 
digestion of the concerned fragment is needed. 
Chemical and enzymatic analysis of TCS protein have also been 
reported previously. Wang (1985) used cyanogen bromide to produce four 
TCS protein fragments for subsequent analysis but no epitope mapping 
data were reported. Ke et al. (1988) used chymotrypsin to produce protein 
fragments from TCS for epitope mapping and they found that amino acid 
residues of 101-247 contain an epitope. 
The location of the epitopes in TCS has been refined in our study as 
compared to Ke et al. (1988). By comparing the results of peptide 
fragmentation, deletion mutagenesis epitope mapping and the epitope 
prediction according to Jameson-Wolf, a clearer picture of the antigenic 







The following table summarizes the information on the antigenic 
determinants of TCS protein found by the two mentioned approaches. 
Antigenic site recognized“ Antigenic site identified by Antigenic site identified by 
by ： deletion mutagenesis fragmentation epitope 
epitope mapping (amino mapping (amino acids 
acids residue of TCS) residue of TCS) 
Monoclonal antibody and 1-21， 1 -73, 
Fab fragment 21-142 1 浦 ？ 
Polyclonal antibody" - 102-153 
a antigenic site recognized by polyclonal antibody only. 
W e have also predicted the antigenic sites of TCS using a computer 
program in DNASIS according to the method of Jameson-Wolf. The 
following table is a summary of the experimental and predicted results. 
Antigenic region recognized by: sequence with high secondary structure 
(amino acids antigenic index of the underlined 
residues) (antigenic index > residues determined 
1.0) by X-ray 
crystallography 
T i l pAb, mAb and random + turn 
Fab structure 
•211^ pAb, mAb and 24-33, 41-46 random + turn 
Fab structure 
154-247 ‘ pAh mAh and 1 7 2 - 1 7 7 , 1 9 1 ^ ~ random + turn 
Fab 206-208 structure 
102-153 pAb , 109-116 random + helix 
structure 
pAb: polyclonal antib6dy 
mAb: monoclonal aritibody , 
Fab: Fab fragment : _ 
109 
The three-dimensional structure of TCS (Fig.5.1, 5.2，5.3 and 5.4) 
show the antigenic region located by deletion mutagenesis and protein 
fragmentation. Many residues are located on random structures which are 
more accessible to antibody interaction. Together with the antigenic index 
prediction, it is very likely that the residues underlined in the above table 





Fig. 5.1. Computer generated 3-D structure of TCS 










Fig. 5.2. Computer generated 3-D structure of TCS 












Fig. 5.3. Computer generated 3-D structure of TCS 







Fig. 5.4. Computer generated 3-D structure of TCS 









5.2 Future Study 
Because the anti-TCS monoclonal antibody and Fab fragment 
recognize the anterior part and posterior part of the TCS protein’ further 
study should be done to find out the exact location of the antigenic site in 
these regions. Moreover the mapping of the Glu-C digested TCS protein 
fragments should give more information on the antigenic site in these 
regions. W e may also use the recombinant method to produce protein 
fragments with amino acid residues between 21-73, 154-247 and 102-153 
for mapping of the antigenic sites involved in this region. Peptide 
fragments such as CI fragment 1, C2 fragment B and C3 of TCS generated 
by cyanogen bromide cleavage can also be isolated by HPLC to perform 
ftirther enzymatic digestion for the further characterization of the antigenic 
sites. Epitope library of TCS (section 1.3) can also be generated for 
locating discontinuous epitope on TCS protein. Moreover, different 
approaches to immunize the animals for generating different clones of 
monoclonal antibody should be used in order to find out all antigenic sites 
of TCS recognized by the immune system. After the immunogenic amino 
acid residues have been found, protein engineering technique can be used 
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